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Abstract 
It is yet unknown how obesity relates with temporal changes in health outcomes and how it 
influences the assessment of body composition and physical activity (PA). The first study of this 
thesis determined that the obesity-associated health outcomes including hypertension and 
dyslipidemia have decreased over the last 15 years while there was an increase in general and 
abdominal obesity (p<0.05). The prevalence of type 2 diabetes has increased only in women with 
general or abdominal obesity (BMI*time; WC*time, p<0.05). There may be other temporal 
changes that have altered how obesity relates with health risks.   
The second study of this thesis determined the importance of the commonly held BIA 
assumptions related to hydration level and fluid distribution in the assessment of body fat (%BF). 
The results showed that there were no differences in the %BF values between the control and 
dehydration, exercise, water and/or food intake, & non-voided bladder test conditions (-1.9 to 
0.4%, p >0.05). Further, no differences in Δ%BF between control and test conditions were 
observed by weight status (overweight: -2.8 to 0.1% and normal weight: -1.7 to 0.5%; BMI*trial, 
p=0.99).  The minor variations in %BF are smaller than what would be expected with weight loss 
interventions and are similar to reported day-to-day variations in BIA.    
Lastly, the third study of this thesis explored differences in objectively measured PA after 
accounting for cardiorespiratory fitness (CRF) and body mass because these variables may 
influence the relative workload of a given PA intensity. After accounting for CRF, the 
individualized cut-offs were higher than the standard cut-offs, wherein men with obesity have 
lower counts per minute (CPM) values than men without obesity (4004 ± 497 CPM versus 5589 
± 372 CPM, p <0.05). Whereas, there was no difference in women by obesity status (p > 0.05).  
However, there were no differences in the PA volume by obesity status with either standard or 
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individualized cut-offs (p >0.05). Despite using individualized CPM cut-offs, the PA durations 
remained similar between those with (28.8 ± 20.3 minutes/day) or without obesity (16.0 ± 16.6 
minutes/day) (p=0.18). Thus, PA performed by individuals with obesity may be under measured 
when assessed by current objective measures.  
Since some of the obesity associated health outcomes have decreased over time, targeted 
efforts may be needed to better define obesity and its health consequences. Further, better 
measures of PA are also needed for individuals with obesity. 
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1.0 General Introduction 
Obesity is defined as abnormal or excessive fat accumulation that may impair health (1). 
However, within a clinical setting, obesity is typically operationalized as having a body mass 
index (BMI) of over 30 kg/m2. Using this metrics, there has been a marked increase in obesity in 
the U.S. with the prevalence of obesity among adults rising from 15% to 36.5% between 1988 
and 2011 (2). Several national surveys have shown that people living with obesity have an 
increased risk of several adverse health outcomes and chronic conditions, notably hypertension, 
diabetes, cardiovascular disease (CVD) and mortality (1,3,4). The prevalence of these chronic 
conditions is expected to continue to increase along with the increasing obesity and places a 
great financial burden on the health care system. Not only has general obesity increased, but so 
has the prevalence of abdominal obesity (5), which is an independent predictor of health risks 
and mortality risk (6,7).  However, it is yet unknown if the temporal increases in abdominal 
obesity may better explain the temporal changes in health risks. Thus, the first objective of this 
thesis was to explore abdominal obesity and its association with health risks and chronic 
conditions over time.  
 Obesity is associated with numerous health risks, and body composition information may 
be useful in further identifying individuals at high risk of developing chronic conditions 
including CVD, diabetes, metabolic syndrome or to monitor disease progression  (8). 
Researchers often use body composition assessment tools such as bioelectrical impedance (BIA) 
devices to better understand and predict differences in health risk.  Thus, it is essential that tools 
used for assessing body composition provide valid and reliable results (9). Therefore, the second 
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objective of this thesis is to investigate factors that may influence BIA measured body 
composition.  
 Lifestyle management including physical activity (PA) is typically recommended as the 
first line for treatment of obesity (10).  It is because PA is associated with many positive health 
outcomes, weight maintenance and reductions in mortality risks (11). It is crucial to use the right 
tools for PA assessment in different populations. Accelerometers are objective tools that are 
commonly used to measure PA.  However, these tools do not account for individual differences 
in factors such as body mass or cardiorespiratory fitness (CRF) which could influence how PA is 
assessed (12). Thus, the third objective of this thesis is to investigate whether the current 
accelerometer universal intensity thresholds are biased against individuals with obesity.  
The overall purpose of the thesis is to gain a better understanding of obesity and its 
association with health outcomes, and how obesity may influence select body composition 
measures and PA assessment measures.   
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2.0 Literature Review 
2.1 Obesity and Health Outcomes 
Obesity, defined by BMI, is associated with numerous health risk factors and increased 
mortality risk from chronic diseases including type 2 diabetes, hypertension, dyslipidemia, 
cardiovascular diseases and stroke  (13). Obesity is one of the most common diseases in the U.S 
(14) and is the fifth leading cause of mortality globally (15). Previous research has predicted that 
the prevalence of type 2 diabetes in the U.S. will increase from ~14% in 2010 to up to 33% by 
2050 (16). Conversely, recent evidence shows that the likelihood of developing certain obesity-
related health risks may have decreased over the last twenty years (17,18).  The prevalence of 
both hypertension and high cholesterol between 1960–62 and 1999–2000 was 12-21% lower 
across all BMI groups (2).  Similarly, there was a linear decline in triglycerides among both men 
(1.38 mmol/L in 2003-2004 to 1.11 mmol/L in 2013-2014) and women (1.24 mmol/L in 2003-
2004 to 1.02 mmol/L in 2013-2014) (19).   
Similar to the general temporal trends in the health risks, previous research has 
demonstrated that individuals with obesity in 1999-2000 had better cardiovascular profiles than 
individuals with obesity in 1960-62 (2). In the later years, there was a linear decline in 
triglycerides and increase in HDL-C levels among individuals with obesity between 1988-1994 
and 2007-2010 (19). The temporal trends with obesity and other health risk factors post 1999-
2000 were not been fully explored but provide preliminary evidence that the better health 
profiles among individuals with obesity over time do not appear to track with rising obesity.   
One of the possibilities for this result is that temporal trends in health risks may not be 
captured adequately by simple measures like BMI. It is because BMI does not account for the 
distribution of body composition and it may influence the risk of developing certain chronic 
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conditions.  Further, other factors including abdominal fat, PA, medications, smoking and diet 
are also independent predictors of health risk.  Some studies have shown that there have also 
been temporal changes in these factors (20–23). Thus, these factors may change how obesity 
relates to health risks over time.  
2.2 Abdominal Obesity and Chronic Conditions 
Although BMI is the most widely used indicator of obesity, it does not take into account 
differences in body composition particularly related to body fat (BF) distribution. Fat that 
accumulates around the abdominal cavity commonly known as abdominal obesity is strongly 
associated with increased risk of hypertension, type 2 diabetes, dyslipidemia and metabolic 
syndrome (8,24).  
Clinically, having a high waist circumference (WC) where a value of 102 cm or higher in 
men and a value 88 cm or higher in women is considered abdominal obesity. Even independent 
of obesity, abdominal obesity is associated with the above mentioned cardio-metabolic health 
risks and mortality risk (6). Between 2003-2014, the prevalence of abdominal obesity increased 
by 5% in men and 4% in women (Men: 59% to 64%; Women: 40% to 44%), while general 
obesity increased by only 2% in men and 5% in women over a similar time frame (Men: 33% to 
35%; Women: 35% to 40%) (5,25). Further, there is evidence that there has been a 
disproportionate increase in WC for a given BMI over time (26). Between 1988–1994 and 2005–
2006, individuals had a 0.9 cm higher WC in the U.S. for a given BMI (27).  Thus, failing to 
account for differences in WC may in part explain the temporal differences in how BMI relates 
in health risks over time.  
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2.3 Body Composition Measurement 
Body composition can also include estimates of percent body fat (%BF) or fat mass 
(FM), fat free mass (FFM), lean body mass, bone mineral content, and total body water (TBW) 
(28).  There are different methods to measure body composition. Anthropometrics could include 
measures of height, body mass and circumferences while %BF, FFM and predicted muscle mass 
is often predicted using methods such as sum of skinfolds, BIA, and dual-energy X-ray 
absorptiometry (DXA). 
Anthropometrics  
 
BMI is calculated as a ratio of height and mass (kg/m²) and is classified as underweight, normal, 
overweight or obesity. Underweight is defined as a BMI of 18.4 kg/m² or lower, normal is 
defined as a BMI of 18.5-24.9 kg/m², overweight is defined as a BMI of 25.0-29.9 kg/m² and 
obesity is defined as a BMI of 30.0 kg/m² or more (29).  BMI is a cost-effective tool that requires 
minimal equipment and minimal technician experience. However, it does not take into account 
regional fat distribution, or muscle mass and therefore may misclassify individuals.   
Sum of Skinfolds 
 
Skinfold method is used to estimate FM and FFM and is based on the assumption that the total 
amount of body fat is directly proportional to the subcutaneous fat (30). A caliper measures the 
thickness of a fold of skin and subcutaneous fat. Based on the number and location of sites used 
to measure skinfolds, different prediction equations are then used to estimate %BF (30). The 
accuracy and reliability for the sum of skinfolds method depends on the technician skill, the 
skinfold sites used, the size of the individual being measured and also the prediction formula 
used (31,32).  Although skinfolds are inexpensive and quick, it requires trained technicians and 
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is subject to inter-observer error. In addition, due to the thickness of the fold, skinfolds may not 
be appropriate for assessing BF in individuals with obesity.   
Dual-energy X-ray Absorptiometry  
 
Dual-energy X-ray Absorptiometry (DXA) estimates three compartments of the body: bone 
mineral content, mineral-free lean mass and FM. These compartments are estimated based on the 
tissue attenuation of two different x-ray energies (33). The x-ray beams pass from the posterior 
to anterior of the body to a detector that is located above the participant (34).  DXA has been 
considered a gold standard method for assessing body composition because of its validity and 
reliability in previous research (8). It is a quick, safe, can be used on almost all populations, and 
requires little pre-testing preparations for the individual (28,33). Although participants are 
exposed to very small amounts of radiation and are safely available for repeated use, DXA 
should not be used in pregnant women. Some other limitations are that the DEXA is costly, 
large, non-portable and the DEXA may require a trained certified technician to operate.   
2.4 Bioelectrical Impedance Devices  
Bioelectrical impedance (BIA) is a safe, fast, non-invasive and relatively inexpensive method for 
assessing body composition (35,36). First introduced in the 1980s as a method of estimating 
body composition, the use of BIA devices has become widespread by both researchers and 
general public (37).  BIA devices use proprietary or published equations that use the relationship 
between total or segmental impedance and total body water (38).  Over the years, the commonly 
used BIA published equations were developed using generally normal weight, healthy 
populations (38).  BIA is based on the principle that when an alternating low-amplitude and high 
frequency potential is applied to the body, the resulting current passes predominantly through the 
path of least resistance which is the water-containing tissues/assumed to be primarily muscle or 
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FFM (39). FFM typically contains approximately 73% water and electrolytes which makes a 
good conductor of electrical current. Thus, impedance to the flow of electrical current passing 
through FFM can be used to estimate body composition, wherein higher impedance is correlated 
with higher FM (37,38).   
BIA can be measured by both single-frequency and multi-frequency BIA devices. Most 
single-frequency devices use a frequency of 50 kHz that usually passes from two different 
points, commonly hand-to-hand, foot-to-foot or hand-to-foot via surface electrodes. Common 
single frequency devices are inexpensive and portable, also referred to as segmental impedance 
analyzers. Conversely, multi-frequency BIA devices estimate body composition using multiple 
frequencies as the different frequencies may better travel through the various tissues. However, 
previous research has shown that single frequency and multi-frequency impedance measures 
show similar estimates of body composition  (28).   
BIA Assumptions  
 
 The BIA equations assume proper hydration and fluid distribution and violating these 
assumptions may alter how BIA estimates FFM and TBW. An individual’s hydration level and 
fluid distribution can vary throughout the day altering the resistive properties of the various body 
tissues (35,38,40).  It is important to investigate how violating the hydration related assumptions 
may change the estimation of body composition. Factors that can influence the hydration status 
and fluid distribution are commonly linked to consumption of food and beverages, non-voided 
bladder, sweating, dehydration and exercise (9,41). Exercise can affect BIA readings in three 
ways: 1) loss of fluid from the body due to sweating, 2) shift in fluid balance between tissues 3) 
increased blood flow to the skeletal muscle and skin which increases heat and would decrease 
the impedance of the current (9,42). Because of the widespread use of BIA technology and these 
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factors, the National Institute of Health recommends the following guidelines prior to taking BIA 
measurement: 
• No eating or drinking for the 4 hours immediately before the test  
• No exercise for the 12 hours immediately before the test  
• Void bladder within 30 minutes prior to the test 
BIA Assumptions and Obesity 
 
The BIA prediction equations used for the BIA measurements are derived from mainly normal 
healthy weight population. Several studies have reported that BIA overestimates FFM and 
underestimates FM in individuals with obesity (37,40,43,44). The reasoning behind the variation 
in BIA estimation among individuals with obesity is not well understood. Baumgartner et al 
propose three hypotheses (40): 1) hydration level and fluid distribution between non-adipose and 
adipose tissues are altered in individuals with obesity and the criterion methods used for 
calibrating prediction equations do not account for these changes; 2) differences in body 
geometry may alter impedance patterns; and 3) high volumes of adipose tissue may contribute to 
a higher conductance in the body. Since current passes through the least resistance, the high 
volumes of adipose tissue may become a ‘parallel tissue-resistor’ resulting in an overestimation 
of muscle or FFM when BIA published equations are applied (45). Thus, the FM in individuals 
with obesity might be underestimated even further after violating any of the BIA guidelines.  
2.5 Obesity and Physical Activity 
Individuals with obesity are generally recommended weight loss to reduce the severity of health 
risk factors and other chronic conditions (46). Weight loss could lead to improvements in many 
cardio-metabolic risk factors including metabolic syndrome, insulin resistance, type 2 diabetes, 
dyslipidemia, and hypertension (46). Previous research has shown that weight loss of even 5% is 
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clinically relevant and is associated with reductions in health risk factors (47). It is generally a 
product of negative energy balance where PA can be performed for energy expenditure.  
PA is defined as any bodily movement produced by skeletal muscles that requires energy 
expenditure and increases heart rate and breathing (48). It is well established that PA is 
associated with many positive health outcomes including reducing obesity-related health risks, 
and better weight maintenance following weight loss (49,50).  Adults who are physically active 
have a lower risk of CVD, type 2 diabetes, hypertension and dyslipidemia than adults who are 
not physically active (51–53). Further, PA can attenuate weight gain in those at risk for obesity 
but is generally associated with only modest weight loss (~2 kg) (54).  
According to public health recommendations, different amounts of PA are recommended 
for health benefits and weight management (54): the moderate-to-vigorous physical activity 
intensity (MVPA) of at least 150 minutes/week is recommended to maintain and improving 
health; at least 150 - 250 minutes/week of MVPA for prevention of weight gain; at least 200-300 
minutes/week for prevention of weight gain after weight loss; and at least 225—420 
minutes/week to promote clinically significant weight loss (54). However, these PA guidelines 
are largely based on studies using self-report PA data and some on doubly labelled water 
measures in studies conducted by the institute of medicine (55,56).  There is an emphasis and 
growing interest for assessing objective PA in interventions and public health initiatives (57).  
2.6 Assessment of Physical Activity 
Methods for the assessment of PA are generally divided into two broad categories: subjective 
and objective measures. Subjective or self-report is the most feasible and cost-effective method 
to measure PA (58,59)  and is a valuable method for providing estimations of the type, duration, 
and intensity of PA in population-based studies (57).  Factors including personal perceptions of 
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activity intensity, recall bias or social desirability, could contribute to the over- or under- 
estimation of PA volume. For these reasons, self-report is commonly not considered as accurate 
as objectively measured PA (60,61).  
The objective measures of PA include direct observation, doubly labeled water and 
activity monitors (i.e. wearable devices and smartphone applications using pedometers, 
accelerometers, fit bits, energy expenditure, pulse rate etc.) (59,62,63). Rapid technological 
advances in the last couple of decades have led to an increased use of activity monitors (59,63). 
The use of pedometers and accelerometers has become increasingly popular in assessing PA 
volume in both general public and research studies. Pedometers are devices that count each step 
by detecting changes in the hip tip. Their accuracy is highly dependent on the placement on the 
person’s hip and keeping the pedometer vertical is vital (64). Tilting the pedometer or wearing it 
at an angle will affect pedometer accuracy drastically and the likelihood of tilt is larger in people 
with high waist circumference or obesity (64). Accelerometers on the other hand measure the 
frequency, duration and intensity of PA (65,66).  
2.7 Accelerometers 
Accelerometers are small devices that are generally worn on the hip in order to capture free-
living PA (67).  These devices are able to distinguish between various types of ambulatory 
activities, such as walking and running (67). Accelerometers are electro-mechanical devices that 
detect and record motion in a single or in multiple planes. They detect accelerations by 
containing sensors that measure linear or angular motions along a single or multiple axis of 
movement  (68). 
The sensors then generate an electric charge to mechanical movements like walking, and output 
a voltage proportional to the acceleration (65,66).  The frequency of accelerations is summarized 
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over a user-defined time, called an epoch, to provide activity counts per epoch commonly 
expressed as counts per minute (CPM) (68). The higher the count, the higher is the intensity of 
PA. Accelerometers can assess the intensity, frequency, and duration of PA, and can thus be used 
to describe both the sum of PA duration and the pattern (distribution at various intensities over a 
defined period, such as a day or a week) of PA. 
Accelerometers by ActiGraph (Pensacola, FL) activity monitors are widely used in PA 
research. One of the original accelerometers, the uniaxial GT1M model measured activity counts 
only in the vertical plane (69,70).  In 2008, ActiGraph enabled dual axes measurement in the 
vertical and antero-posterior axes, and PA was assessed using a composite vector magnitude of 
these two axes. In 2009, ActiGraph released the triaxial GT3X activity monitor. The GT3X 
measures acceleration in three individual orthogonal planes (vertical plane, antero-posterior 
plane and medio-lateral plane). It provides CPM values as a composite vector magnitude of these 
three planes (VM3) (71). Thus, GT3X accelerometers may allow for more accurate field-based 
PA estimates as it is capable of detecting movements in any plane.   
 
2.8 Influence of Cardiorespiratory Fitness and Body Mass on Accelerometers 
According to Freedson et al. (2011), accelerometer output is typically processed by calibrating 
the device in a laboratory by simultaneously recording accelerometer output (e.g., CPM) and 
physiological variable (e.g., oxygen consumption) (71).  Oxygen consumption is often expressed 
in metabolic equivalent of tasks (MET), wherein 1 MET corresponds to an oxygen consumption 
of 3.5 milliliters of oxygen per kilogram of body mass per minute (mL·kg-1·min-1). (72).  The 
relationship between CPM and METs are often used to create cut-points that denote differences 
in activity intensity. The VM3 accelerometer cut-points by Freedson are among the most 
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commonly used: moderate intensity PA (MET: 3.00) = 2690 CPM, for vigorous intensity PA 
(MET: 6.00) = 6167 CPM, and for very vigorous PA (MET: 9.00) = >9642 CPM (71).  
However, the use of a single CPM threshold does not account for the individual 
differences in how the CPM values relate with PA intensity. In particular, classification of PA 
using MET values does not account for age, sex, type of activity, individual perceived effort or 
relative intensity of the given activity (57).  Samples from the accelerometer validation studies 
often consist of young male participants and it may or may not be reflective of the more general 
population as CRF levels can influence the relative perceived effort required for a given absolute 
PA intensity (73).    
An individual with a higher level of fitness will be performing the given activity at a 
lower relative intensity compared to the individual who is less fit. For example, walking at a pace 
of 4.8 km/h corresponds to 3 MET (2690 CPM) may be perceived as moderate effort for one 
individual, and vigorous effort (higher relative %VO2 peak workload) for another, depending on 
their CRF.  Further, age is associated with declines in CRF and older populations are more likely 
to have a higher perceived effort at any given absolute intensity thresholds (74). The MET values 
of 6-9 are typically related to vigorous intensity PA, however, it is estimated that in older 
individuals who are between 65–79 years of age, vigorous intensity PA, corresponds to only 4.8 
to 6.7 METs (74).  Similar to age, CRF levels also differ between sexes where men have higher 
levels of CRF than women (75). Thus, low CRF values could lead to underestimating the relative 
PA intensity associated with any given CPM value (12). 
Previous research has reported that individuals with obesity have lower CPM values 
when compared to individuals with normal weight (76).  However, similar to CRF, body mass 
could also lead to changes in how PA is assessed using accelerometers (77). The force needed to 
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generate an acceleration is positively related to the mass of the object (Force = mass x 
acceleration). Thus, individuals with high body mass would need to do more work than 
individuals with low body mass to achieve the same acceleration frequency.   
This would mean that individuals with obesity who generally have low CRF and high body mass 
may work at a even higher relative intensity (%VO2 peak) at any given CPM, therefore 
underestimating the volume of PA even further.  
2.9 Self-report Physical Activity & Obesity 
Research has typically shown that individuals with obesity tend to report more PA than is 
completed when PA is assessed using subjective measures (67,78). Given the large differences 
reported between self-report and accelerometer PA duration, individuals with obesity are often 
the victim of weight stigma and social desirability and are assumed to be over-reporting their PA 
levels (79). However, the large differences between PA volumes could be due to the fact that 
accelerometers do not account for the individual perceived effort or relative intensity of PA 
given the differences in body mass and CRF explained earlier. Rather, individuals with obesity 
may perform a high amount of PA but the total volume may not be captured accurately, given the 
assumptions that underlie objective measures of PA. As previously described, accelerometers do 
not account for CRF and body mass differences leading to underestimation of PA volume in 
individuals with obesity. Therefore, it is important to investigate if the standard CPM thresholds 
bias against individuals with obesity, and if the factors including CRF and body mass could 
explain some of the differences observed between subjective and objective PA measures.   
2.10 Summary & Objective 
In summary, both general and abdominal obesity have increased over time and they are both 
associated with greater prevalence of chronic conditions (5).  However, it is yet unknown how 
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the temporal changes in abdominal obesity relate with the temporal trends in chronic conditions.  
Secondly, BIA is one of the common body composition assessment methods and there are 
several guidelines related to ensuring proper fluid distribution and hydration levels in the body 
(80).  However, the validity of these guidelines and their impact on BIA assessed body 
composition have not been thoroughly investigated, particularly in populations with obesity. 
Lastly, individuals with obesity are often recommended PA as the first line treatment strategy 
(54).  PA is typically monitored using subjective measures including self-report and objective 
measures including accelerometers. The PA volume reported by self-report are generally higher 
than the accelerometers (79), and the differences could be related to differences in how 
accelerometers capture PA in individuals with obesity, because accelerometers do not account 
for individual differences in factors such as body mass or CRF (12). Therefore, the three 
objectives of the dissertation were:  
Objective 1: To examine the temporal trends of obesity-associated health risks after accounting 
for temporal differences in factors including abdominal obesity, PA, total caloric intake, smoking 
and medications taken between 1999-2014.  
Objective 2: To examine the effects of water intake, dehydration, food intake, exercise, and 
bladder voiding on acute BIA measurements and if the effects are influenced by BMI categories.  
Objective 3: To determine CPM values during light (30-35% VO2peak) and moderate to 
vigorous (MVPA) PA intensity (≥50% VO2peak) physical activity. Further, to estimate and 
compare durations of objectively measured PA to the self-report measured PA across BMI using 
standard CPM thresholds and individualized CPM intensity thresholds that account for 
differences in CRF.  
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3.0 Manuscript 1: Changes in the Prevalence of Chronic Conditions 
Associated with Abdominal Obesity between 1999-2014 
Abstract 
Objective: To examine the temporal trends of obesity-associated chronic conditions after 
accounting for temporal differences in body mass index (BMI), & waist circumference (WC). 
Method: Pooled cycles (1999-2014) of the U.S. National Health and Nutrition Examination 
Survey (NHANES) were analyzed (n=36,959). The models were adjusted for total caloric intake, 
smoking, age, numbers of medications taken and being physically active. Results: The 
prevalence of diabetes increased only in women with general or abdominal obesity (BMI*time; 
WC*time, p<0.05) and there were no changes in men.  Independent of BMI, the prevalence of 
hypertension remained similar over time in both sexes (time, p > 0.05), whereas for a given WC, 
there was a decrease in the prevalence of hypertension over time in women (WC*time, p = 0.05). 
Similarly, the prevalence of dyslipidemia decreased in men independent of BMI, while for a 
given WC, there was a decrease in the prevalence of dyslipidemia in both sexes (time, p <0.05). 
Over the same time frame, blood pressure, LDL and triglycerides decreased, while plasma 
glucose and HDL increased in both sexes independent of general and abdominal obesity (p< 
0.001). Conclusion: Whereas obesity is associated with several chronic conditions, there may be 
other temporal changes that have altered how obesity is related with such markers of metabolic 
health. Further investigation is needed to better understand the causes of the temporal changes in 
these chronic conditions.  
 
Key words: Obesity, Abdominal obesity, Chronic Conditions, Health Risk Factors, NHANES 
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Introduction 
Obesity is notably associated with numerous health risk factors and increased mortality 
risk from chronic conditions including type 2 diabetes, cardiovascular disease and stroke (1,3,4). 
However, the relationship of these chronic conditions with BMI may have varied over time 
(2,19).  For example, there was a 10.1% temporal increase in prevalence of diagnosed diabetes 
among adults with obesity from 1960-62 to 1999-2000 using the BMI metric (2).   Conversely, 
between 1960 and 2000, the prevalence of hypertension and high cholesterol in adults with 
obesity has decreased (-14% and -12% respectively) (2). In a similar vein, there is evidence that 
the mortality risk associated with obesity may have also decreased over the years (17).   
While not yet fully understood, the differences in the health risks associated with obesity 
over time may in part be associated with the limitations of simple measures of obesity such as 
BMI. This is supported by the finding that WC, a more sensitive correlate of health risk (81,82), 
has been increasing for a given BMI over time (26). Lifestyle factors such as total caloric intake, 
physical activity (PA), smoking and medication use have also varied over time (20,21,83,84).  
Thus, failing to account for differences in WC and these lifestyle factors over time, may in part 
explain the temporal differences in how BMI contributes to health risks over time.  
The purpose of the current study is to therefore examine the temporal trends of obesity-
associated health risks after accounting for temporal differences in factors including BMI, WC, 
total caloric intake, smoking, age, number of medications taken, ethnicity, education and PA 
between 1999-2014.  
 
 
17 
Methods 
Overall Design and Study Population 
 The data was obtained from the National Health and Nutrition Examination Survey 
(NHANES). NHANES is a series of nationally representative cross-sectional surveys of civilians 
living in the contiguous U.S. As a stratified, complex, multistage, probability-based survey, 
NHANES oversamples older adults, low-income individuals and certain racial/ethnic groups.  
The complete details of the study design and procedures are reported elsewhere (10). Data for 
this study was obtained from pooling NHANES continuous surveys from 1999 to 2014.  
Sample Size 
 Across all survey years, a total of 82,091 participants were interviewed.  Analyses were 
based on the data collected from participants aged 18 years and older (n= 47,356).  Participants 
were excluded additionally if data was missing on measured BMI (n=4,113), total caloric intake 
(n = 2,521), total grams of fat consumed (n=22), WC (n=992), education (n=35), number of 
prescription medications taken (n=28), and smoking status (n=2,687). The final sample size for 
complete case analysis was 36,959 persons aged 18 years and older (1999-2000, n = 4,040; 
2001-2002, n = 4,362; 2003-2004, n= 4,185; 2005-2006, n = 4,261; 2007-2008, n= 5,099; 2009-
2010, n= 5,429; 2011-2012, n= 4,519; 2013-2014, n=5,064). 
Measures 
Informed consent was obtained from all participants, and ethics approval was obtained 
from the NHANES Institutional Review Board for the NCHS Research Ethics Review Board for 
the NHANES continuous surveys.  
Interview and examination measures 
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Questionnaires were used to assess age, sex, ethnicity (white or other), and education (≤ 
high school or > high school). Body mass, height and WC were measured by trained health 
technicians in a mobile examination center using standardized techniques and customized 
equipment. Body mass was measured on a digital weight scale (Mettler Toledo, Ohio, US). 
Standing height was measured in inches with a fixed stadiometer with a moveable headboard. 
WC was measured using a steel measuring tape to the nearest 0.1 cm at the high point of the iliac 
crest at minimal breathing.   
Cholesterol data including total cholesterol (TC), triglycerides, HDL-C and LDL-C was 
conducted on venous blood serum samples and was standardized for cholesterol measurements 
according to the criteria of the CDC–National Heart, Lung, and Blood Institute Lipid 
Standardization Program. The samples were frozen at −30°C and shipped weekly on dry ice to 
the laboratory conducting the lipid analyses. TC and triglycerides were measured using 
enzymatic reactions. HDL-C and LDL-C were measured by the direct immunoassay method 
during 2007-2010, whereas in 1999-2002, the heparin manganese precipitation method was 
primarily used (19). Blood pressure was measured according to standard protocols of the CDC 
(86). Measurements were conducted in the mobile examination center on participants in a seated 
position. Diabetes was assessed by measures of fasting plasma glucose, hemoglobin A1C,  two-
hour glucose test and the serum insulin using human insulin immunoassay method in the 
morning examinations session only (87). The laboratory methods for all blood samples were 
consistent in the continuous surveys, and the details regarding specimen collection and 
processing instructions are described elsewhere (88). 
Diet information was retrieved from 24-h dietary recall questionnaire with additional 
questions about how food was prepared.  In NHANES 1999 - 2002, a multiple-pass computer-
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assisted dietary interview format was used to collect detailed self-reported information about all 
foods and beverages that were consumed the day prior to the in-person interview (weekday or 
weekend). In NHANES 2003 onwards, 24-h self-reported dietary recalls were performed twice 
(3-10 days apart) using an automated multiple pass method. To keep the dietary data consistent 
with the NHANES 1999-2002, only day 1 data was used for dietary recalls in the following 
years. For all surveys, the data was used to estimate the total number of calories (kcal/day), fat 
(g), protein (g) and carbohydrates (g) from the foods and beverages consumed.  
Smoking information was retrieved from the participants by asking, “Do you now smoke 
cigarettes?” and “Have you smoked at least 100 cigarettes in your entire life?”  Both questions 
were asked to everyone including the non-smokers. Current smoking was defined as a positive 
answer to both questions.  
 PA information retrieved was self-reported where participants were asked questions 
based on exercise, sports, and physically active hobbies that were performed during leisure time 
on a typical day.  PA categories (active or non-active) were formed where only activities that 
were at least moderate intensity were included in our definition of being active. Information was 
retrieved by asking, “Did you do any moderate activities for at least 10 minutes that cause only 
light sweating or a slight to moderate increase in breathing or heart rate?”  or “Did you do any 
moderate-intensity sports, fitness, or recreational activities that cause a small increase in 
breathing or heart rate such as brisk walking, bicycling, swimming, or golf for at least 10 
minutes continuously?” or  “Did you do any vigorous-intensity sports, fitness, or recreational 
activities that cause large increases in breathing or heart rate like running or basketball for at 
least 10 minutes continuously?” or  “Did you do any vigorous activities for at least 10 minutes 
that caused heavy sweating, or large increases in breathing or heart rate?” Active was defined as 
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a positive answer to any of the four questions meaning active for at least 10 minutes of moderate 
or vigorous PA intensity on a typical day.   
In all the NHANES surveys, information about prescription medication use was assessed 
during a household interview. Participants were asked if they had taken prescription medication 
over the past 30 days. Those who responded “yes” were asked to show the containers of the 
medication, and if unavailable, participants were asked to report up to 23 medication names. 
Medications were linked to a prescription medication database (Lexicon Plus) that includes all 
prescription medications classes. Medication classes for commonly used prescribed medications 
including antihypertensives, lipid-lowering medications, and antidiabetics were created using the 
prescription medication database. Antihypertensive drugs were coded to include agents for 
hypertensive emergencies, angiotensin converting enzyme, antiadrenergic agents, peripherally 
acting, centrally acting, beta-adrenergic blocking agents, calcium channel blocking agents, 
diuretics, peripheral vasodilators, antihypertensive combinations, angiotensin II inhibitors, 
vasopressin antagonists, aldosterone receptor antagonists, renin inhibitors, cholinergic agonists. 
Lipid-medication drugs were coded to include antihyperlipidemic agents, HMG-CoA reductase 
inhibitors, miscellaneous antihyperlipidemic agents, fibric acid derivatives, bile acid 
sequestrants, cholesterol absorption inhibitors, antihyperlipidemic combinations, and 
miscellaneous metabolic agents. Antidiabetic drugs were coded to include antidiabetic agents, 
and miscellaneous metabolic agents. 
Definitions of Primary Outcomes 
Hypertension was defined as: systolic blood pressure (SBP) of at least 140 mm Hg and/or 
diastolic blood pressure (DBP) of at least 90 mm Hg using the cuff-size–corrected 
measurements, previously diagnosed hypertension (by self-report) or the reported use of 
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antihypertensive drugs in the past 30 days.  Dyslipidemia was defined as: TC (> 6.20 mmol/L), 
low HDL-C as sex-specific (men: <1.04 mmol/L; women: <1.29 mmol/L), high LDL-C ( ≥ 4.14 
mmol/L), high triglycerides (>1.7 mmol/L), previously diagnosed high cholesterol (by self-
report) or the reported use of anti-lipid drugs used in the last 30 days. Type 2 diabetes was 
defined as: a plasma glucose level of at least 7 mmol/L (126 mg/dl or higher), hemoglobin A1C 
of at least 6.5%, previously diagnosed diabetes (by self-report) or reported use of antidiabetic 
drugs in the past 30 days.  
Abdominal obesity was defined as high WC (men, >102 cm; Women, > 88 cm). BMI 
categories were defined as normal weight (BMI, 18.5 to 24.9 kg/m2), overweight (BMI, 25 to 
29.9 kg/m2) and obesity (BMI, >30 kg/m2).  
Statistical Analysis 
Sample characteristics were shown as mean ± SE and prevalence ± SE stratified by sex 
and survey year. The differences between sample characteristics across survey years were 
assessed using one-way analysis of variance (ANOVA) with Tukey’s post hoc tests for 
continuous variables and chi-square tests for categorical variables within each sex. Due to high 
collinearity between BMI and WC, two separate models were run with BMI categories (normal 
weight, overweight, and obesity) or abdominal obesity to determine the temporal trends of the 
health risks and prevalence of chronic conditions.   
 Multivariable linear regression analysis was used to determine the relationship between 
triglycerides (mmol/L), HDL (mmol/L), LDL (mmol/L), plasma glucose (mmol/L), SBP 
(mmHg),  DBP (mmHg) and time.  Analyses were conducted in men and women separately 
while adjusting for WC (or BMI), total caloric intake, PA, smoking, age, average number of 
medications taken in the last 30 days, ethnicity, and education.  Similarly, multivariable linear 
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regression analyses were also used to estimate the prevalence of each chronic condition (i.e. 
dyslipidemia, hypertension, & type 2 diabetes) in two separate models (BMI categories; WC 
categories) while adjusting for total caloric intake, number of medications taken in the last 30 
days, PA, smoking, age, ethnicity, and education.  For dyslipidemia, the model was adjusted for 
total grams of fat intake instead of total caloric intake.  
All analyses applied clinic survey weights and were conducted using survey procedures (SAS 
version 9.4; SAS Institute, Cary, NC) to ensure the national representativeness of the data. 
Statistical hypotheses were tested using a two-sided α = 0.05 level.   
Results  
Participant characteristics for each survey year are shown in Table 1.1 for men and 
women separately. From 1999 to 2014, the proportion of individuals with abdominal obesity 
increased in both sexes (men; 37.4 ± 1.9% to 45.6 ± 1.1 %, women; 59.0 ± 2.3 to 67.5 ± 1.3%) 
(Table 1.1). More specifically, both BMI and WC increased from 1999 to 2005 in men and then 
it remained stable in the later years while both measures increased from 1999 to 2014 in women 
(p <0.05).  At the same time, the prevalence of dyslipidemia remained stable in men (57.9 ± 1.4 
to 56.6 ± 1.4%) while there was a reduction (61.7 ± 1.7 to 54.7 ± 1.5%) in women (Table 1.1). 
The most dramatic changes were observed for the prevalence of type 2 diabetes which increased 
by 32.8% in men and 30.3% in women between 1999 to 2014 while the rates of hypertension 
increased by 12.9 % in men and remained stable in women (Table 1.1).  
In our main analysis, the prevalence of chronic conditions (hypertension,  dyslipidemia, 
&  type 2 diabetes) and temporal trends in health risk factors (triglycerides (mmol/L), plasma 
glucose (mmol/L), SBP (mmHg), DBP (mmHg), HDL (mmol/L) and LDL (mmol/L)) with BMI 
and WC were explored (Figure 1.1 to 1.3).  Overall, both BMI and WC were independently and 
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positively associated with increases in prevalence of chronic conditions and health risks in both 
sexes (p <0.001), even after adjustment for total caloric intake, PA, average number of 
medications taken in the last 30 days, total grams of fat consumed (only for dyslipidemia), 
smoking, age, ethnicity, and education.   
Independent of BMI, the prevalence of hypertension remained similar from 1999 to 2014 
in both sexes (time, p > 0.05, Figure 1.1). Similarly, for a given WC, the prevalence of 
hypertension remained similar over time in men (time, p= 0.95, Figure 1.2). However, there was 
a small decrease in the prevalence of hypertension that was only observed among women with 
abdominal obesity (53.5 to 50.3%) from 1999 to 2014 (abdominal obesity*time, p = 0.05). Over 
the same time frame, SBP (mmHg) and DBP (mmHg) decreased in both sexes (Figure 1.3, time, 
p< 0.001). 
For a given BMI, the prevalence of dyslipidemia decreased only in men, whereas for a 
given WC, the prevalence of dyslipidemia decreased in both sexes (time, p <0.05) (Figure 1.1 & 
1.2). Similar to the prevalence of dyslipidemia, the lipid risk factors have also improved over 
time (p < 0.001). For a given BMI or WC, triglycerides, and LDL decreased, while HDL 
increased over time in both sexes (Figure 1.3, time, p< 0.001). 
For a given BMI or WC, the prevalence of type 2 diabetes increased in women (time, p 
<0.05) while no change was observed in men (time, p > 0.05) (Figure 1.1 & 1.2). For example, 
in the BMI model, the increase in the prevalence of diabetes was only observed among women 
with obesity (17.7% to 22.4) while there were minimal differences in the prevalence among 
normal weight and overweight from 1999 to 2014 (BMI*time, p < 0.001, Figure 1.1). Similarly, 
in the WC model, the increase in prevalence was only observed among women with abdominal 
obesity (16.7 to 19%) while there was no change among women without abdominal obesity (3.1 
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to 3.5%) from 1999 to 2014 (abdominal obesity*time, p < 0.001, Figure 1.1). In both sexes, 
there was also a temporal increase in plasma glucose (Figure 1.3).  
 Discussion 
Much of the rise in chronic conditions is often attributed to the rise in obesity.  Obesity is often 
described using measures such as BMI.  However, independent of BMI, we document a 
substantial decrease in the prevalence of dyslipidemia in men and increase in the prevalence of 
type 2 diabetes in women over the last 15 years. The decreased prevalence of dyslipidemia and 
increased prevalence of diabetes was also seen when we accounted for temporal differences in 
abdominal obesity.  Thus, these findings suggest that there may be temporal changes (or co-
occurring) that have altered how obesity relates to chronic conditions.  
There was a temporal decrease in the prevalence of dyslipidemia in both sexes while the 
prevalence of hypertension decreased only among women with abdominal obesity. Others have 
previously documented that there has been a disproportionate increase in WC for a given BMI 
(27,89,90). Given that WC is often cited to be a stronger correlate of health risk, it would follow 
that there should also be a rise in dyslipidemia and hypertension that mirrors the increased 
prevalence of abdominal obesity over time. In the same vein, there were temporal decreases in 
measured health risk factors (e.g. triglycerides, LDL, SBP, and DBP) (Figure 2), results that 
extend previous work showing temporal reductions in dyslipidemia and hypertension (2,19,91). 
Our results indicate that changes in the prevalence of general or abdominal obesity, total caloric 
intake, total grams of fat intake, number of medications taken, and PA had little effect on the 
overall trends in hypertension and dyslipidemia.  The net result of these phenomena may be a 
population that is with high BMI but lower risks for these metabolic health markers. These 
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results reinforce the notion that there is a wide range in health profiles that present between 
individuals with the same BMI or even WC.  
The decrease in the prevalence of dyslipidemia could be associated to the introduction of 
more efficacious prescription medications and an increased use of lipid-lowering medications 
(21,92). Introduction of atorvastatin, a highly effective drug, in the early 2000s for dyslipidemia 
led to over 20% more prescriptions than any other statin medications by the year 2014 (92). 
Further, some improvements in lipids profile can be attributed to reductions in trans-fatty acids, 
increased consumption of nuts & seeds and fish & shellfish intake (23). Trans-fatty acids can 
raise LDL cholesterol and lowers HDL cholesterol while daily intake of 3-4 grams of omega -3 
fatty acids derived from fish & nuts can reduce triglycerides by 20 -50%  (93). Thus, the changes 
related to medications and certain dietary habits could potentially contribute to the observed 
improvements in triglycerides, LDL, and HDL measures.  
The decrease in the prevalence of hypertension among women with abdominal obesity 
may in part be due to more effective control, reduction in the use of hormone replacement 
therapy and increased usage of certain medications. First, we observed that the temporal decrease 
in SBP was greatest among adults with hypertension, which may indicate better hypertension 
control over time. Second, the use of hormone replacement therapy among women declined to 
5.06% in 2010 from 24.62% in 2000 (18). Given that the use of hormone replacement therapy 
was associated with the increased risk of coronary heart disease, and stroke in post-menopausal 
women, the decline in the use of hormone replacement therapy may reflect the decreased 
prevalence of hypertension among women (94).  Lastly, in our prior study, we showed that there 
has been temporal increases in anti-hypertensive therapy among women with obesity (21).  
Certain anti-hypertensives such as angiotensin converting enzymes (ACE) inhibitors and 
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angiotensin receptor blockers (ARBs) were associated with better blood pressure profiles for 
women with obesity than leaner women (95). Together, this suggests that medications may have 
played a role in reducing BP, but particularly among women with obesity. However, the use of 
ACE inhibitors are also associated with increased blood glucose levels in women (95). Thus, 
medications could also be one reason why there are different trends in blood pressure than type 2 
diabetes, despite both being obesity-related comorbidities.  
Contrary to the temporal trends in dyslipidemia and hypertension, the prevalence of type 
2 diabetes had increased with a greater degree over time in women with obesity or abdominal 
obesity. This means that a woman with either obesity or abdominal obesity is more likely to have 
type 2 diabetes now than 15 years ago even after adjusting for total caloric intake, PA, age, 
smoking, ethnicity and number of medications taken. A higher prevalence of type 2 diabetes is 
reflected in the temporal increase in plasma glucose observed in this study and an increased 
likelihood of taking antidiabetics among women with obesity (21).  Over the last 15 years, the 
proportion of undiagnosed diabetes cases decreased to 11% in 2005-2010 (96). This may suggest 
that there have been improvements in the screening, and diagnosis particularly among women 
with obesity. In addition to the use of ACE inhibitors being associated with increased blood 
glucose levels in women, there might be other factors that could contribute to the rise in type 2 
diabetes. First, the increasing consumption of high-fructose corn syrup (HFCS) has been linked 
to ectopic fat accumulation leading to insulin resistance, and thus increased type 2 diabetes risk  
(97,98). Second, there is an emerging evidence between insulin resistance and gut microbiome 
(99). The gut microbiome may cause a greater energy extraction from the dietary substances and 
chronic low-grade inflammation, both leading to greater insulin resistance and type 2 diabetes 
(100).  Finally, advancing maternal age has been associated with gestational diabetes mellitus 
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and women with a history of gestational diabetes mellitus have a greater risk of developing type 
2 diabetes (101,102). These factors may contribute to the increases in the prevalence of type 2 
diabetes in women but nonetheless warrants further investigation.   
Some strengths and limitations of the study are worth mentioning. One of the strengths of 
this study is that it used a large sample size and documented health risks over 15 years within a 
nationally representative sample of the U.S. To our best knowledge, it is the first study that has 
looked at the prevalence of chronic conditions with general and abdominal obesity using BMI 
and WC while accounting for major lifestyle factors. Further, the health risk data was obtained 
during laboratory examinations as well as through home interviews by trained technicians. Given 
that the definitions of the chronic conditions presented in the study are based on both measured 
and self-report values, the prevalence of the chronic conditions may be underestimated (103). It 
is important to highlight that the study is limited by the use of self-reported PA and dietary data 
and may result in over or under reporting of these measures. Unfortunately, as objectively 
measured physical activity is currently only available for NHANES 2003–2006, we cannot 
determine temporal changes in self-report bias in PA over time. Similarly, the 24 h food recall 
questionnaire may not accurately reflect an individual's typical diet.  
In summary, our analysis showed that independent of obesity, the prevalence of diabetes 
has increased in women while the prevalence dyslipidemia has decreased in men over the last 15 
years. Further, for a given level of abdominal obesity, the prevalence of hypertension has 
decreased in women. Our findings show that the decreased prevalence of dyslipidemia and 
hypertension do not reflect the increasing prevalence of obesity or abdominal obesity in women. 
It suggests that there may be other temporal changes that have altered how obesity is related with 
the chronic conditions. Further investigation is needed to better understand the causes of the 
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temporal changes in the chronic conditions associated with obesity as determined by BMI and 
WC.    
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Table 1.1.  Baseline Characteristics of US Adults by NHANES Surveys.   
 NHANES 
(1999-2000) 
NHANES 
(2001-2002) 
NHANES 
(2003-2004) 
NHANES 
(2005-2006) 
NHANES 
(2007-2008) 
NHANES 
(2009-2010) 
NHANES 
(2011-2012) 
NHANES 
(2013-2014) 
Men  Sample (n) 1904 2074 2025 2044 2517 2645 2273 2442 
Age (years) 45.0 ± 0.5 45.1 ± 0.6 45.4 ± 0.5 45.5 ± 0.8 45.8 ± 0.5 46.3 ± 0.5 46.4 ± 0.9 45.4 ± 0.4 
Ethnicity (%, white) 71.2 ± 2.7 73.5 ± 2.5 73.3 ± 3.2 73.3  ± 2.6 69.4  ± 3.6 68.6  ± 3.3 68.5 ± 3.9 66.9 ± 3.0 
Education (%, > HS) 50.2 ± 2.7 56.2 ± 2.0 54.8 ± 1.6 56.9 ± 2.4 54.0  ± 3.1 58.1 ± 1.6* 61.4 ± 2.9* 60.8 ± 2.1* 
BMI (kg/m2) 27.9 ± 0.2 28.0 ± 0.1 28.2 ± 0.1 28.7 ± 0.2* 28.5 ± 0.1* 28.8 ± 0.2* 28.6 ± 0.2* 28.8 ± 0.1* 
Physically active (%) 62.1 ± 1.9 68.5 ± 1.6* 66.7 ± 1.5* 68.9 ± 2.1* 57.0 ± 3.1* 56.9 ± 1.3* 58.2 ± 2.7* 56.7 ± 1.3* 
Caloric Intake (Kcal/d) 2580± 31 2625 ± 38 2684 ± 31* 2683 ± 39 2566 ± 31 2556 ± 40 2586 ± 25 2493 ± 22* 
Smoke (%) 27.1 ± 1.6 26.8 ± 1.3 29.0 ± 1.3 27.6 ± 1.6 25.9 ± 1.7 21.6± 1.0* 23.9 ± 1.6 19.7± 1.0* 
Waist circumference 
(cm) 
99.2 ± 0.5 99.7 ± 0.3 101.0 ± 0.4* 101.6 ± 0.8* 101.1 ± 0.5* 101.4 ± 0.6* 101.5 ± 0.6* 101.7 ± 0.4* 
Abdominal Obesity 
(%) 
37.4 ± 1.9 39.1 ± 1.1 43.3 ± 1.2* 45.1 ± 2.3* 43.7 ± 1.7* 44.1 ± 1.8* 44.6 ± 1.7* 45.6 ± 1.1* 
Number of Medications 
Taken  
1.1 ± 0.1 1.3 ± 0.1 1.6 ± 0.1* 1.5 ± 0.1 1.7 ± 0.1* 1.7 ± 0.1* 1.7 ± 0.1* 1.8 ± 0.08*  
Chronic Conditions 
(%) 
Dyslipidemia 
Type 2 Diabetes 
Hypertension 
 
 
57.9 ± 1.4 
9.0 ± 0.6 
36.3  ± 2.2 
 
 
57.5 ± 0.9 
9.9 ± 0.7 
35.3 ± 1.9 
 
 
53.4 ± 1.9 
11.0 ± 0.8 
40.4 ± 1.7 
 
 
56.7 ± 1.8 
9.8 ± 0.8 
40.5 ± 1.6 
 
 
59.7 ± 1.2 
12.6 ± 0.6* 
40.5 ± 1.3 
 
 
58.0 ± 1.2 
13.4 ± 1.0* 
40.7 ± 1.8 
 
 
57.2 ± 1.5 
12.6 ± 1.0* 
41.0 ± 1.7 
 
 
56.6 ± 1.4 
13.4 ± 0.8* 
41.7 ± 1.1* 
Women Sam    ple (n) 2136 2288 2160 2217 2582 2784 2246 2622 
Age (years) 46.9 ± 0.5 46.2 ± 0.5 46.8 ± 0.6 46.8 ± 0.8 47.4 ± 0.5 47.45 ± 0.5 47.8 ± 0.8 46.5 ± 0.4 
Ethnicity (% white) 68.3 ± 3.3 72.5 ± 2.6 72.4  ± 3.6 71.2  ± 2.9 69.8  ± 3.7 68.0  ± 3.7 67.3 ± 3.9 66.3 ± 3.4 
Education (%, > HS) 48.5 ± 2.2 56.3 ± 1.9* 56.5 ± 1.7* 59.0 ± 1.7* 56.2 ± 2.1* 59.1 ± 1.2* 66.6 ± 2.4* 63.9 ± 2.5* 
BMI (kg/m2) 28.6 ± 0.3 28.4 ± 0.2 28.6 ± 0.3 28.8 ± 0.3 28.8 ± 0.2 29.0 ± 0.3 29.2 ± 0.2 29.4 ± 0.3* 
Physically active (%) 54.8 ± 2.2 63.2 ± 1.6* 65.6 ± 1.3* 67.4 ± 1.4* 48.9 ± 2.3 48.6 ± 1.4* 54.2 ± 2.5 53.5 ± 1.7* 
Caloric intake (Kcal/d) 1835 ± 28 1844 ± 20 1860 ± 17 1812 ± 23 1813 ± 26 1801 ± 13 1864 ± 20 1858 ± 16 
Smoke (%) 20.4 ± 1.3 21.5 ± 1.3 21.6 ± 1.3 20.1 ± 1.2 19.3 ± 1.3 18.0 ± 1.0 15.9 ± 1.3* 17.8  ± 1.5 
Waist circumference 
(cm) 
93.5 ± 0.8 93.5 ± 0.5 95.1 ± 0.5 94.8 ± 0.7 95.8 ± 0.5* 96.3 ± 0.3* 97.2 ± 0.6* 97.5 ± 0.6* 
Abdominal Obesity 59.0 ± 2.3 59.2 ± 1.5 64.1 ± 1.8 61.5 ± 1.8 64.2 ± 1.6* 65.5 ± 1.3* 68.3 ± 2.1* 67.5 ± 1.3* 
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(%) 
Number of Medications 
Taken 
1.8 ±0.1 1.9 ± 0.1 2.2 ± 0.1* 2.2 ± 0.1* 2.2 ± 0.1* 2.1 ± 0.1 2.1 ± 0.1 2.2 ± 0.1* 
Chronic Conditions 
(%) 
Dyslipidemia 
Type 2 Diabetes 
Hypertension 
 
 
61.7 ± 1.7 
8.5 ± 0.8 
38.3 ± 1.8  
 
 
54.5 ± 1.0* 
8.2 ± 0.7 
37.1 ±1.5 
 
 
53.8 ± 1.9* 
10.0 ± 0.8  
41.3 ± 1.6 
 
 
52.9 ± 1.9* 
10.2 ± 0.9 
38.0 ± 1.6 
 
 
58.1 ± 1.4 
11.7 ± 0.9* 
40.2 ± 1.3 
 
 
55.9 ± 1.1 
10.9 ± 0.6* 
37.1 ± 1.5 
 
 
58.5 ± 1.9 
11.7 ± 0.9* 
38.8 ± 1.2 
 
 
54.7 ± 1.5* 
12.2 ± 0.8* 
40.3 ± 1.4 
All the continuous values are presented as means ± SE and categorical values as prevalence (SE) %. HS = high school, BMI = body 
mass index, WC = waist circumference. The values are weighted to be nationally representative. * = significantly different from 1999-
2000 (p<0.05). Physically active was defined as percentage of people being active for at least 10 minutes of moderate PA intensity on 
a typical day.   
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Figure 1.1 
 
 
Figure 1.1. The prevalence (%) of type 2 diabetes, dyslipidemia and hypertension with BMI in 
both sexes. The model was adjusted for age, education, ethnicity, total calories consumed in a 
day, number of medications taken in the last 30 days, smoking, and being physically active. For 
dyslipidemia, total calories consumed in a day were replaced by total grams of fat intake in the 
model.   
*: significantly different from normal weight in the year 1999, p < 0.05.  
OB = Obesity, OW=Overweight, NW = Normal weight, BMI = Body Mass Index  
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Figure 1.2  
 
 
Figure 1.2. The prevalence (%) of type 2 diabetes, dyslipidemia and hypertension with 
abdominal obesity (abob) in both sexes. The model was adjusted for age, education, ethnicity, 
total calories consumed in a day, number of medications taken in the last 30 days, smoking, and 
being physically active. For dyslipidemia, total calories consumed in a day were replaced by total 
grams of fat intake in the model.  *: significantly different from no-abob in the year 1999, p < 
0.05.  
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Figure 1.3  
 
Figure 1.3. The trends of triglycerides (mmol/L), plasma glucose level (mmol/L), systolic blood 
pressure (mmHg), diastolic blood pressure (mmHg), HDL (mmol/L) and LDL (mmol/L) with 
time for both sexes. The models were adjusted for age, education, number of medications taken, 
ethnicity, total calories consumed in a day, smoking, and being physically active.  The trends 
were very similar when BMI was replaced with WC in the model. For TG, HDL and LDL, total 
calories consumed in a day were replaced by total grams of fat intake in the model.   
*: significantly different from the same sex in the year 1999, p < 0.05.  
WC = Waist Circumference, BMI = Body Mass Index 
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4.0 Manuscript 2: No Differences in the Body Fat after Violating Core 
Bioelectrical Impedance Measurement Assumptions 
Abstract 
Objective: It is unclear to what degree acutely violating bioelectrical impedance analysis (BIA) 
measurement assumptions will alter the predicted percent fat mass (%FM) and whether this 
differs by body mass index (BMI) category. Methods: %FM was assessed under control, 
dehydration, moderate intensity treadmill exercise for 15 minutes, water and/or food intake, non-
voided bladder acute conditions with three BIA devices (Tanita: BC-418, TBF-314, & Omron 
HBF-306CN) (n=40). Results: For all BIA devices, there were no differences in the %FM values 
between the control and the other conditions (-1.9 to 0.4%, p >0.05). There were no differences 
in %FM between control and the conditions when examined by BMI category (overweight: -2.8 
to 0.1% and normal weight: -1.7 to 0.5%; BMI*trial, p=0.99). To determine the relative 
contribution of impedance and body mass to the differences in %FM, a model with standardized 
estimates was examined.  Across the various conditions, differences in FM were more strongly 
associated with differences in impedance than body mass. Conclusion: %FM estimates were 
similar despite acutely violating the preliminary measurement BIA assumptions across a range of 
different BMIs.  The minor variations in %FM are smaller than what would be expected with 
weight loss intervention.   
 
Key words: Bioelectrical impedance, body composition, BMI, obesity  
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Introduction 
Bioelectrical Impedance Analysis (BIA) is a convenient, non- invasive and non-intrusive   
device for estimating body composition (104,105).  BIA devices use proprietary or published 
equations based on the relationship between total or segmental impedance and total body water 
volume  (106).  BIA equations for predicting body composition are based on the premise that 
when an alternating electric current is applied to the body, the amount of current that passes 
through the conductive water-containing tissues is related with the amount of fat free mass 
(FFM) presumed to be muscle tissue only.  The impedance to the flow of electrical current can 
be used to estimate  body composition where higher or greater electrical impedance is correlated 
with higher fat mass (38,106,107).  These equations assume proper hydration and fluid 
distribution and violating this assumption may alter how BIA estimates FFM and total body 
water. Accordingly, the National Institute of Health recommends avoiding BIA measurements 
when participants are dehydrated, within 4-h of food and beverage consumption, have a full 
bladder and within 12 hours of moderate-to-strenuous exercise (80).  
The commonly used BIA published equations  were  developed  using normal weight 
(18.5 to 25 kg/m2), generally healthy populations  (38,106).    Some studies suggest that BIA 
analyses underestimate the percent fat mass (%FM) in individuals with overweight or obesity 
(>25 kg/m2), and may be related to differences in fluid distribution, resistive and volume 
properties among various body tissues (39,40). It is important to understand if violating these 
preliminary measurement BIA assumptions changes the estimation of body composition and if 
these discrepancies are greater among those with overweight or obesity as classified by body 
mass index (BMI). 
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  Furthermore, the relative importance of the preliminary BIA measurement assumptions 
may vary across devices.  Impedance can be assessed using foot to foot, hand to foot and hand-
held devices. Some of the common BIA devices used in research studies are: (1) Tanita Body 
Composition Analyzer, Model: BC-418  (hand-to-feet), (2) Tanita, Model TBF-314 (foot-to-
foot), and (3) Omron Fat Loss Monitor, Model: HBF-306CN (hand-to-hand).  Because of the 
differences in the tissues through which the main electrical current travels through the body, the 
assumptions may influence BIA %FM differently depending on the device used.  These devices 
vary by electrode characteristics (number, type and placement), electric current frequency (single 
or multiple frequencies) and body position at measurement (108).  Thus, it is important to 
investigate the preliminary BIA assumptions across various devices.  
Therefore, the aim of this study was to examine the effects of water intake, dehydration, 
food intake, exercise, and bladder voiding on acute BIA %FM & impedance measurements and 
if the effects are influenced by BMI categories.  
Methods 
Participants 
Students and staff from York University were recruited via posters to participate in this study. 
Interested individuals were contacted through emails where the study objectives were further 
explained and questions about the visits answered. The inclusion criteria were: (a) age 18-70 
years, (b) able to speak/read English, and (c) screened through Physical Activity and Readiness 
Questionnaire for Everyone (PAR-Q+, www.eparmedx.com). Anthropometric data was obtained 
on height, body mass, waist, hip, ankle, bicep, wrist and waist circumference. Height and body 
mass were measured using a wall mounted measuring tape and digital scale respectively. Waist 
circumference was obtained on iliac crest of participants. Weight status was determined by using 
 
 
37 
the BMI equation:  body mass (kg)/height (meters)2. Participants completed a questionnaire on  
age, sex, education, ethnicity, fluid and food intake, and current medications. 
Written informed consent was obtained by all participants and ethics approval was obtained from 
the Human Participation Review Sub- Committee, York University’s Ethic Review Board 
(certificate #: e2012-283).  
Protocol 
The three BIA devices used included the : (1) Tanita Body Composition Analyzer, Model: BC-
418  (hand-to-feet), (2) Tanita, Model TBF-314 (foot-to-foot), and (3) Omron Fat Loss Monitor, 
Model: HBF-306CN (hand-to-hand). These three BIA devices measure segmental impedance 
where the placement of polar electrodes are varied. The two Tanita devices output total and 
regional body composition and impedance data while the Omron machine only outputs total 
percent body fat.  
Visit 1: 
At the first visit, participants were tested under three conditions (water trial, non-voided 
bladder trial and exercise trial) along with the control trial. Participants were instructed to drink 
3L of water the day prior to testing to ensure proper hydration. In addition, participants were 
instructed to (1) abstain from exercise on the day of the visit, (2) fast for 4-5 hours prior to their 
visit and (3) not void their bladder for at least 2 hours before the visit.  
At the laboratory, participants were given 5 minutes to drink 1L of water and then shortly 
after underwent  a BIA measurement (water trial). After 30 minutes they had a BIA measurement 
with their bladder still unvoided (non-voided bladder trial). Within 30-40 minutes of ingesting 
water, the volume of stomach contents usually return to the original state before the water intake 
(109).  Participants then voided their bladder on a urine reagent test strip (10 LG Parameter 
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Urine Reagent Strips, Craig Medical Distribution, CA, USA) to test urine specific gravity (110). 
The following reference values were used to determine hydration status: 1-1.010 indicates 
relative hydration, and a value of 1.020 or greater indicates relative dehydration (111).  Once the 
hydration levels were reached (1-1.010 on the urine reagent test strip), the BIA assessment was 
repeated (control trial).   
Participants were then asked to run/speed walk on a treadmill at a moderate intensity (50-
70% of age predicted HRmax using 220-age) for 15 minutes and  then undergent BIA 
measurements again (exercise trial). Following the exercise for 15 minutes, the BIA 
measurement was repeated.  
All the participants followed the same order of BIA measurements starting with water 
trial, then non-voided bladder trial, control trial and then followed by exercise trial on Visit 1. 
The order was kept consistent to keep the time between conditions consistent and limit any 
carry-over effect.  
Visit 2: 
Prior to coming to the laboratory for the second visit, particpants were asked to: (1) 
abstain from exercise on the day of the visit, (2) fast for 4-5 hours prior to their visit and (3) not 
void their bladder for 2 hours before the visit. In addition participants were instructed to not 
consume any fluid for 5-8 hours prior to the assessment. Upon arrival, participants  voided their 
bladder on a urine reagent test strip to ensure that they were dehydrated prior to BIA assessment. 
Once the dehydration level was ensured, the BIA measurement was taken (dehydrated trial).  
Afterwards participants were given 30 minutes to consume a meal ad libitum (325 g Dr. 
Oetker Ristorante Mozzarella Pizza (Kcal: 880, Fat: 44g, CHO: 76g, Protein: 36g), Pringles 
Original (Per 16 chips, Kcal: 150, Fat: 9g, CHO: 15g, Protein: 1g), and  water.  After confirming 
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that participants had returned to adequate hydration status, we then measured BIA (food intake 
Trial).  
Visit 3: 
Participants underwent  a Dual-energy X-ray Absorptiometry (DXA), total body 
composition assessment (bone mineral content, %FM, FFM)  using a General Electric Lunar 
Prodigy  (GE, USA).  
 Skinfold measurements were measured three times using caliper (Harpenden Skinfold 
Caliper, Model: CE 0120) at the triceps, biceps, subscapular, iliac crest and medial calf to 
estimate %FM. The %FM was calculated using Durnin JV and Womersley equation (32).  
Statistical Analysis 
Statistical analysis was  performed using SAS verion 9.4 (SAS Institute Inc., Cary, N.C., 
USA), with a level of statistical significance set at an alpha of 0.05. Means and standard 
deviations (M ±SD) were used to describe sample characteristics. A repeated measures ANOVA 
was used to compare %FM and impendance in each of the conditions (water intake, dehydration, 
food intake, exercise, and non-bladder voiding) compared to the BIA control trial for each BIA 
machine, and Sum of Skinfolds  and DXA in both sexes. Post hoc analysis using Tukey multiple 
comparison test was used to determine differences among BMI groups in their %FM and 
impedance variations amoungst trials. Lastly, we conducted the multiple regression analyses to 
identify the relationship of change in  impedance and body mass with %FM. The standardized 
estimates (expressed per standard deviation) were used to facilitate comparisons between the 
impedance and body mass beta estimates.  The relationships between %FM, impedance and 
condition trials had one outlier: a female who was removed from all the analyses owing to the 
large variability in body mass fluctuations between the visits.  
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Results 
The participant characteristics are shown in Table 2.1 for men and women separately. 
The BMI ranged from 20.2 to 37.8 kg/m2 for both men and women.  
Influence of various factors on BIA measurements 
Percent Fat Mass 
The %FM was assessed using three BIA devices (Tanita BC-418, Tanita TBF -314, and 
Omron HBF) under control, dehydration, exercise, water and/or food intake, and non-voided 
bladder conditions are shown in Figure 2.1 for men and women separately. For all BIA devices, 
there were no differences in the %FM values between the control and any of the condition trials 
(range: -1.9 to 0.7%, p >0.05). Further, the differences in %FM between control and each 
condition trial was not significantly influenced by BMI (BMI*trial, p=0.99).  
Impedance 
Impedance tested using two BIA devices (Tanita BC-418, and Tanita TBF -314) under 
various conditions (control, dehydration, exercise, water and/or food intake, non-voided bladder) 
are shown in Figure 2.2 for men and women separately. For both Tanita devices, there were no 
differences in the impedance values between the control and any of the condition trials (range: -
26.6 to 3.1 Ω, p >0.05). Similar to %FM values, the differences in impedance between control 
and each condition trial was not significantly influenced by BMI (BMI*trial, p=0.99).  
Further analyses were conducted to understand if changes observed in %FM between the 
condition and control trials were more strongly related to changes in impedance or body mass. 
In Table 2.2, the relationship between impedance and body mass with %FM in the 
control and condition trials are shown.  The values of impedance and body mass for each 
condition are shown as the intra-individual difference between the control and the condition trial. 
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During the control trial, total body impedance was more strongly related to %FM than body mass 
(standardized estimates; impedance, 5.13 to 8.48%, body mass, 4.89 to 5.59%). Similarly, we 
observed that the changes in total body impedance from the control trial were more strongly 
related with changes in %FM than changes in body mass for both Tanita BC-418 and TBF-314 
(Table 2.2). For example, one standard deviation change in impedance was associated with a 
0.16 to 1.32% difference in FM while one standard deviation change in body mass was 
associated with a 0.22 to 0.79% difference in FM under various BIA conditions (Table 2.2).   
Discussion 
Our findings suggest that acutely violating the preliminary measurement BIA 
assumptions has minimal influence on the derived %FM and impedance values. Further, the 
minor differences in the measurements were similar among all participants regardless of their 
body mass.  
The use of BIA devices to assess body composition is common in health and fitness 
facilities and research studies. Although the preliminary measurement BIA assumptions are well 
known and accepted, they are rarely followed in practice.  BIA measurements are recommended 
to be avoided when participants are dehydrated, within 4-h of food and beverage consumption, 
and within several hours of moderate-to-strenuous exercise (80).   
In terms of water and food intake, there is no consistency on the direction of change.   
Similar to other studies in the literature (35,112), we report non-statistically significant 
differences in %FM of ~1%, while others showed a statistically significant increase in %FM (~ 
1.7%) after water and/or food intake (113,114). Studies with significant increases in %FM 
consumed high carbohydrate (white plain bread, fruit jam, and banana) or high fat (croissant, 
cheddar cheese, butter, full-fat Greek style yogurt) meals with water or high electrolyte sport 
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drinks. Similarly, the present study used a high fat meal, while other studies with non-significant 
differences had non-specified/ad libitum food and beverage intake (35,112) . Nonetheless, %FM 
differences were modest and were inconsistent in their direction of change, and differences of 
approximately 1% associated with food and beverage intake are likely within the expected 
deviations with day-to-day variation (115).   The composition of the diet is likely to influence 
body impedance and the rate of gastric emptying, however, one study reports that impedance 
values are similar even after many hours after consuming the meal (116).  
The non-voided bladder condition did not significantly change the impedance or %FM 
values when compared to the control trial.  Although, the consumption of 1L of water did 
increase body mass, it was not enough to statistically increase %FM.  In this study, 1 kg 
difference in body mass is associated with a 0.68% difference in FM which is in line with a 
previous study theorizing that a non-voided bladder could affect BIA measurements by up to 1% 
(117).  Thus, non-voided bladder is likely to have minimal effects on %FM estimates.   
There are several changes that occur with exercise such as changes in skin blood flow, 
temperature, heat production and fluid loss (116), that may increase or decrease impedance. The 
literature on the effects of acute exercise on estimated %FM and impedance is mixed with 
studies showing decreased impedance by 28-40 Ω (118), or no change in impedance following 
moderate intensity aerobic exercise (118–120) as observed in this study. In the literature, the 
largest differences observed are less than 1% FM even with exercise moderate to vigorous 
intensity of 60 to 83% HRmax for as long as 45 minutes. These minimal differences suggest that 
moderate intensity exercise is likely being associated with minimal differences in predicted 
%FM.  
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For dehydration, theoretically one would expect an increase in impedance and %FM with 
low fluid status. In this study, impedance was not significantly increased in the dehydration 
condition, and in fact trended in the opposite direction (-22.4Ω to -7.4Ω) and %FM (-1.9 to 
0.4%).  This was the largest difference in %FM observed in the current study (maximum 
difference 1.9%, dehydration versus -0.2 to 1.01%, other conditions).  A study conducted by 
Thompson et al (1991) also report a significant decrease in %FM in the dehydrated state when 
compared with the control state however the exact %FM difference was not reported  (121). 
However, the study had its participants achieved the dehydration state by exercising for 30 
minutes and then sitting in a steam room to decrease body mass by an average of 2.81% which is 
much larger than what we saw in our study (<1%). In this study, we examined each factor in 
isolation and it is unclear whether the differences in %FM may be larger when the core BIA 
assumptions are violated in combination.  Nevertheless, the maximal 2% FM difference observed 
in this study is far lower than the 15 to 19.5% reduction in FM that would be typically expected 
in exercise intervention even with minimal weight loss  (122).  In the dehydration condition, the 
change of 2% FM is likely due to the reduction of average body mass of -0.74 kg among 
participants.   
It has been known that there are different hydration levels, fluid distribution and volume 
properties in those within different BMI categories (104,123).  Different tissues offer varying 
resistance; for example, adipose tissue is classified as a poor conductor of current because of the 
lower water content. Thus, BMI classified normal-weight individuals have hydration levels of 
~73% (124) while the hydration levels are assumed to be lower in those with overweight and 
obesity (125–127).  Thus, one would expect the effect of dehydration or exercise to vary in 
people with different BMI categories. However, despite our large range in BMI (20.2 to 37.8 
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kg/m2) the difference in %FM that resulted by violating the preliminary BIA assumptions are 
similar among all participants. Further, these measures were generally comparable to DXA and 
sum of skinfolds (SOS) %BF assessments.  The exception was the Omron HBF (hand-to-hand 
model) in women where the %FM values were significantly lower than DXA and SOS.  This 
reinforces the notion that %FM obtained cannot be directly compared between the various 
devices, but also suggests that the acute violation of the core BIA assumptions may not have a 
large influence on the %FM obtained regardless of the measurement site used.  Further, these 
variations in %FM are far smaller than what one would expect with clinical weight loss 
interventions (128).  Retrospective power analyses suggest that 182 participants would be needed 
for the largest difference (-2%FM) to be significant and 11 million participants for the smallest 
difference (-0.008%). Regardless of the statistical significance, the clinical relevance of these 
variations are questionable as they are comparable to be what would be expected with the 2 to 
5% day-to-day variation (18,33).   
Some strengths and limitations of this study are worth mentioning. We are one of the few 
studies to examine the effect of acutely violating the core BIA assumptions on the estimation of 
body composition among multiple BIA devices. In the current study, three BIA devices with 
different measurement sites were used. Although there are several different devices available on 
the market, they all use measures of impedance and body weight to assess body composition.  
Since we observed no differences in impedance, it suggests that these observations likely hold 
true for other BIA devices using different algorithms. However, we are unsure if the differences 
in body composition would be larger if more than one core BIA assumption was violated at the 
same time. Further, although we had a large range in obesity using the BMI metric, the sample 
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was generally normal weight or overweight using BMI.  Finally, we are unsure if our results 
extend to older individuals or populations with chronic conditions. 
It can be concluded that acutely preliminary measurement BIA assumptions have a very 
small effect (<2%) on the derived %FM and impedance values. These differences associated 
with acutely violating the core BIA assumptions are far smaller than what would be expected 
with weight loss interventions and is within what is expected with day- to- day variation.   
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Table 2.1. Sample Characteristics of Participants by Sex  
 Men Women 
Total Sample  n=23  n=17 
Age (years) 24.0 ± 5.2 22.5 ± 3.4 
BMI (kg/m2) 25.9 ± 3.5 22.8 ± 2.8* 
BIA Body Fat (%) 
     BC-418 
     TBF-314 
     Omron HBF 
DXA Body Fat (%) 
Skinfolds Body Fat (%) 
 
19.7 ± 6.6 
20.0 ± 6.7 
17.8± 6.7 
20.7 ± 9.0 
19.0 ± 5.5 
 
29.4 ± 6.9* 
27.1 ± 6.4* 
24.4 ± 5.8* 
30.1 ± 8.4* 
29.1 ± 5.4* 
Waist Circumference (cm) 79.6 ± 15.5 76.2 ± 6.2 
BIA Impedance (Ω) 
     BC-418 
     TBF-314 
 
560.2 ± 65.6 
479.5 ± 52.7 
 
728.0 ± 88.8* 
581.3 ± 68.9* 
All the continuous values are presented as means ± SD and categorical values as prevalence %.  
BMI = body mass index, BIA = Bioelectrical Impedance 
* = significantly different from men (p<0.05) 
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Table 2.2. Change in %FM with Changes in Impedance and Body Mass after violating the 
preliminary measurement BIA assumptions 
Baseline BIA Total Body Impedance Body Mass  
  Partial 
R 
Parameter 
Estimate 
(%FM/Ω) 
Standardized 
Estimate 
(%FM/SD of 
Ω) 
Partial 
R 
Parameter 
Estimate 
(%FM/SD 
of kg) 
Standardized 
Estimate 
(%FM/SD of 
kg) 
Control trial  
 
BC-418 0.83 1.03  8.48% 0.70 0.68 5.59% 
TBF-314 0.59 0.69  5.13% 0.57 0.66 4.89% 
Trial BIA Change in %FM with Impedance  Change in %FM with BM 
  Partial 
R 
Parameter 
Estimate 
(%FM/Ω) 
Standardized 
Estimate 
(%FM/SD of 
Ω) 
Partial 
R 
Parameter 
Estimate 
(%FM/SD 
of kg) 
Standardized 
Estimate 
(%FM/SD of 
kg) 
Water intake 
(condition 1) 
BC-418 0.82 0.75 0.79 0.85 0.23 0.24 
TBF-314 0.81 0.53 0.34 0.85 0.62 0.40 
Voided Bladder 
(condition 2)  
BC-418 0.95 0.75 0.52 0.85 0.38 0.27 
TBF-314 0.75 0.54 0.16 0.83 0.72 0.22 
 Exercise 
(condition 3) 
BC-418 0.85 0.80 0.55 0.55 0.32 0.22 
TBF-314 0.80 0.72 0.34 0.69 0.50 0.24 
Dehydration  
(condition 4) 
BC-418 0.92 0.90 1.31 0.81 0.54 0.79 
TBF-314 0.93 0.90 1.18 0.84 0.54 0.71 
Food intake 
(condition 5) 
BC-418 0.94 0.94 1.32 0.73 0.35 0.49 
TBF-314 0.92 0.94 1.13 0.66 0.35 0.42 
Standardized estimates are expressed as %change in fat mass per one standard deviation change 
in impedance or body Mass. The values of impedance and body weight for each condition were 
shown as the intra-individual difference between the control and the condition trial.  
FM = Fat Mass, BM = Body Mass 
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Figure 2.1 
 
Figure 2.1. The average percent fat mass for each trial per BIA machine for men (n=23) and 
women (n=17). There were no differences between trials for each BIA machine for percent fat 
mass (p >0.05). BMI=  Body Mass Index 
 * = Significantly different from DXA  
 †= Significantly different from sum of skinfolds 
R = refers to the control or reference condition 
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Figure 2.2 
 
Figure 2.2. The average bioelectrical impedance for each condition per BIA Tanita machine for 
men and women. There were no differences between conditions for each BIA machine for 
impedance from the reference group (R) (p >0.05).  BMI = Body Mass Index 
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5.0 Manuscript 3: Are Different Accelerometers Cut-Offs Needed to 
Accurately Determine Physical Activity Intensity? 
 
Abstract 
Objective: To determine if accounting for cardiorespiratory fitness (CRF) and body mass index 
(BMI) significantly impact the accelerometer cut-offs for assessing physical activity (PA) 
partcipation. Methods: After completing the incremental to maximum VO2 test, participants (≥ 
20 years, n=41) performed ten 3-4 minute intervals alternating between light intensity (30-
35%VO2 peak) and moderate to vigorous intensity MVPA (≥50% VO2 peak) while wearing an 
accelerometer on the right hip. The CPM values derived using standard cut-offs and individual 
CRF cut-offs were compared by BMI in both sexes. Results: After accounting for CRF, the 
individualized cut-offs were tended to be higher than the standard cut-offs for only light intensity 
PA (p <0.05).  Wherein men with obesity had lower CPM values during light and moderate 
intensity PA compared to men without obesity, there were no differences in CPM values in 
women with obesity despite differences in CRF and body mass (p >0.05). Moreover, no 
differences in PA duration between those with (28.8 ± 20.3 min/day) or without obesity (16.0 ± 
16.6 min/day) were observed when applying individualized or standard CPM cut-offs (p=0.18). 
In contrast, self-reported PA duration was higher in men with obesity (178 ± 11.6 min/day) than 
men without obesity (115.8 ± 15.9 min/day, p <0.05) while there was no difference in women 
(p>0.05). Discussion: Our findings suggest that even when accounted for CRF, the PA duration 
was similar between individuals with or without obesity. Future research may be needed to better 
understand how to translate CPM values into PA intensity for people with overweight and 
obesity.  
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Introduction 
It is well established that physical activity (PA)  is associated with many positive health 
outcomes such as reducing obesity-related health risks and better weight maintenance following 
weight loss (11,130,131). Methods for the assessment of PA are generally divided into two 
categories: subjective and objective measures. Subjective or self-report PA is widely used in 
population based studies (57), however, it is not considered as accurate as objectively measured 
PA (60,61) as factors including personal perceptions of activity intensity, recall bias or social 
desirability, could contribute to the over- or under- estimation of PA volume  (79).   
Accelerometers are objective tools to measure PA and are commonly used in research 
settings to measure the frequency, duration and intensity (aka volume) of PA. Accelerometers 
generate an electric charge to mechanical movements like walking, and outputs a voltage 
proportional to the acceleration (65,66).  The frequency of accelerations per minute is called 
counts per minute (CPM).  In accelerometers, there are single universal CPM threshold values to 
denote light intensity PA (0-2689 CPM or MET value ≤ 3), moderate intensity PA (2690-6166 
CPM or MET value = 3 to 6), and vigorous intensity PA (6167-9642 CPM or MET value = 6 to 
9) (71).  However, the use of a single threshold does not account for the individual differences in 
how the CPM values relate with PA intensity. For example, the force needed to generate an 
acceleration is positively related to the mass of the object (Force = mass x acceleration). Thus, 
individuals with high body mass would need to do more work than individuals with low body 
mass to achieve the same acceleration frequency.  In addition, cardiorespiratory fitness (CRF)  
will further influence the relative work required for a given absolute PA intensity (73).  For 
example, playing tennis corresponding to 5.0 MET (2690-6167 CPM) may be perceived as 
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vigorous effort for one individual and very vigorous effort (higher relative % VO2 peak 
workload) for another.  
Accordingly, a study conducted by Ozemek et al. (41) showed that individuals with low 
CRF had lower CPM values than those with high CRF fitness when working at moderate or 
vigorous intensity (40 and 60% of heart rate reserve (HRR)) (12). This would imply that 
individuals with obesity who generally have low CRF and high body mass may work at a even 
higher relative intensity (%VO2 peak) at any given CPM, therefore underestimating the volume 
of PA in those with obesity.  Thus, both CRF and body mass may contribute even further to the 
discrepencies observed between subjective and objective measures of PA (42).  
As far as we know, it is yet unknown if CRF could contribute to the discrepancies in 
CPM values between individuals with and without obesity.  
Purpose and Aim 
The purpose of the study is twofold:  
1) To determine CPM values during light (30-35% VO2peak) and moderate to vigorous (MVPA) 
PA intensity (≥50% VO2peak) physical activity. 
2) To estimate and compare durations of objectively measured PA to the self-report measured 
PA across BMI using standard and individualized CPM intensity thresholds that account for 
differences in CRF.  
Methods 
Data was obtained from recruiting participants at York University through posters. 
Interested individuals were contacted through email where the study objectives were further 
explained and questions about the visits were answered. Participants over the age of 20 years 
were screened using the 2014 /2015 Physical Activity Readiness Questionnaire for Everyone: 
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2014/2015PAR-Q+ and if necessary the ePARmed-X+ at www.eparmedx.com (132). Written 
informed consent was obtained and the study protocol ethical approval was obtained from York 
University Human Participants Research Committee (certificate # e2015 -145)  
The participants were stratified by sex and obesity status.  No-obesity group was defined 
by the body mass index (BMI) of ≤ 30 kg/m2  and no abdominal obesity (waist circumference; 
men ≤ 88 cm, women ≤ 102 cm). Obesity group was defined by the BMI of  ≥ 30 kg/m2 or 
abdominal obesity (waist circumference; men ≥88 cm, women ≥ 102 cm). The data was collected 
at 2 different visits that were 7 days apart. Of the 62 participants that attended the 1st visit, 41 
participants completed both visits and were included in these analyses. An honorarium of $25 
was given to the participants at the completion of the study. 
Protocol 
First Visit 
 After screening for eligibility and receiving consent, participants underwent 
anthropometric and body composition measures. A series of anthropometric measures including 
height, body mass, leg length, stride length, waist circumference were collected.  
Participants completed a 5 minute warm-up and then underwent a modified Balke maximal effort 
exercise test on a treadmill using indirect calorimetry while wearing an accelerometer and a heart 
rate monitor.  
Participants were provided a GT3X+ Actigraph Accelerometer (Penascola, FL) to record PA 
over a one week period. The GT3X is a tri-axis accelerometer that measures accelerations in 
three individual orthogonal planes (vertical plane, antero-posterior plane and medio-lateral 
plane). It provides CPM values as a composite vector magnitude of these three axes. Participants 
wore a PA monitor on their right hip during waking hours for a period of seven days. The CPM 
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values for 1-second epochs were retrieved and summed for the entire duration. Only participants 
with at least 4 out of 7 days of wear time were used in the analyses. One of the wear valid days 
had a weekend day and a minimum of 10 waking hours.  
Second visit 
On the second visit, participants returned the accelerometer, and performed ten 3-4 minute 
intervals alternating between walking/jogging at light (30-35%VO2 peak) and moderate-vigorous 
intensity PA (MVPA, ≥50% VO2 peak) on a level surface. Intensity was monitored using heart 
rate (HR) monitors with HR targets that corresponded to the appropriate VO2 ranges assessed 
during the first visit. CPM values in 1-second epochs were taken over 1 minute after achieving 
steady state.  
 Self-reported PA from the previous week (same time-period the accelerometer was worn) 
was obtained using the International Physical Activity Questionnaire – long form (IPAQ). IPAQ 
self-reported PA was estimated in five domains: occupational PA; active transportation PA; 
domestic and yard work PA; leisure-time PA; sitting time; and three PA intensities: (1) walking; 
(2) moderate PA; (3) vigorous PA.  IPAQ outcomes for specific domains, intensities, and totals 
were calculated in minutes per week (133). The IPAQ has been demonstrated to have adequate 
reliability ranging from 0.74-0.97 (134).   
Objective PA Assessment  
CPM measured during the light (57-63% HRmax) and moderate (64-76% HRmax) intensity 
bouts were aligned with the measured HR during the same 1-minute steady state period. To 
improve comparability with the global PA guidelines, CPM values that corresponded to 60% and 
75% of HRmax were presented.   
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Accelerometer measured durations of moderate PA, vigorous PA, and MVPA intensities 
over 7 days were determined as moderate and/or vigorous activity performed in bouts of at least 
10 minutes. The duration of 10 minutes had an allowance of up to 2 minutes below the intensity 
thresholds (67,135). The two intensity thresholds used were standard CPM cut-offs and 
individualized CPM cut-offs calibrated based on the individualized CRF level for each 
participant.  
The standard CPM cut-offs were based on Freedson (2011) adult intensity cut-points; 
light; 0-2689 CPM, moderate; 2690-6166 CPM, vigorous; 6167-9642 CPM, and very vigorous; 
9643 and above (69,71) 
The individualized CPM cut-offs were based on the CRF levels and derived from the 
individual algorithms that corresponded to light (57% HRmax) and moderate (76% HRmax) 
intensity (136). The PA volume was calculated using standard and individualized CPM cut-offs 
by using the ActiLife v6.13.3 (Pensacola, Florida) program.    
Statistical Analysis 
Continuous variables were reported as mean ± SD. Participant characteristics were 
stratified by sex and obesity status based on BMI, where ANOVA was used to compare 
continuous variables. The models were adjusted for age (years) and leg length (cm). Differences 
by PA assessment method and PA intensity by obesity status were assessed using repeated 
measures analysis of variance with least-squared differences post hoc comparisons tests.  
All statistical analyses are conducted using SAS version 9.4. Statistical significance is 
considered at p< 0.05.   
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Results 
Participant characteristics by obesity status and sex are presented in Table 3.1. In general, CRF 
was lower among those with obesity than those without obesity (p<0.05), and in women 
compared to men (p<0.05).  
Measured CPM values during light and moderate intensity PA by obesity status 
 CPM values measured during PA bouts corresponding to light intensity (60% HRmax), 
and moderate intensity (75% HRmax) stratified by obesity status and sex are shown in Figure 3.1. 
During both light intensity and moderate intensity PA, men with obesity (light, 4004 ± 497; 
moderate, 6481± 835 CPM values) had significantly lower CPM values compared to men 
without obesity (light, 5589 ± 372; moderate, 9601± 625 CPM values, p<0.05) (Figure 3.1).  
However, in women there were no significant obesity-related differences in the CPM values 
during light or moderate intensity PA (light - women with obesity 4540 ± 475 vs women without 
obesity, 3335 ± 622 CPM; moderate - women with obesity, 7269 ± 505 vs women without 
obesity, 6247 ± 662 CPM;) (Figure 3.1, p>0.05).  
Comparison of Standard and Individualized CPM cut-offs 
The individualized CPM cut-offs that correspond to ACSM thresholds for light (57% HRmax), 
moderate (64% HRmax) and vigorous (77% HRmax) for each participant are shown in Figure 3.2. 
The vigorous intensity PA cut-offs were extrapolated for each individual based on their relative 
CRF and HR. For comparability, the standard CPM cut-offs proposed by Freedson are also 
shown on the Figure as shaded area. The vast majority of individualized CPM cut-offs were 
higher than the standard cut-offs for light PA intensity for both sexes (p <0.05). Wherein the 
differences between the two cut-offs were significantly lower in men with obesity than men 
without obesity for light intensity PA (p <0.05). Conversely, the difference between the standard 
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and individualized CPM cut-offs was not different in women by obesity status for light intensity 
PA (p> 0.05).  For moderate and vigorous PA intensities, there were no differences between the 
individualized and standard cut-offs (p >0.05) where only 20 to 27% of the individuals had 
higher or lower individualized CPM values than the standard cut-offs.  
 Objective versus subjective measurement 
Mean durations (minutes/day) of PA using individualized and standard CPM cut-offs, and self-
report PA by obesity status for both sexes is shown in Figure 3.3. As expected, mean durations 
of PA using self-report were significantly longer than durations of PA estimated by 
accelerometer using either CPM cut-offs regardless of sex or obesity status (Figure 3.3, p 
<0.05).  
Self-reported moderate PA and MVPA intensity durations were significantly higher in 
men with obesity (MVPA, 178 ± 11.6 minutes/day) than men without obesity (MVPA, 115.8 ± 
15.9 minutes/day) (Figure 3.3, p <0.05). In women, there was no difference in self-reported 
moderate PA and MVPA intensity durations by obesity status (women with obesity, 144.7 ± 13.2 
vs. women without obesity, 126.4 ± 17.4) (p > 0.05). It is opposite to what we see when PA 
volume is measured using the standard CPM cut-offs, wherein individuals with obesity had 
lower MVPA durations (men, 53.7 ± 20.3 minutes/day) than individuals without obesity though 
this difference did not reach significance (men, 89.9 ± 16.6 minutes/day, Figure 3.3, p = 0.25). 
Similarly, the PA volume based on individualized CPM cut-offs were not different between 
individuals with or without obesity in either sex (p =0.18). Men with obesity had performed 28.8 
± 20.3 minutes/day of MVPA and men without obesity had performed 16.0 ± 16.6 minutes/day 
of MVPA.  Further, regardless of the PA assessment method used, the proportion of individuals 
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meeting the Canadian PA guidelines remained similar between individuals with or without 
obesity (range, 46% to 54%).  
As the individualized CPM cut-offs were not different than the standard CPM cut-offs for 
moderate and vigorous PA intensities (Figure 3.2), it is expected that the PA durations using the 
individualized CPM cut-offs would not be different than PA durations with standard cut-offs for 
PA intensity across sex and obesity status (Figure 3.3, p>0.05). However when comparing 
within groups, the PA durations using the individualized CPM cut-offs were significantly  
shorter than the PA durations with standard cut-offs among men without obesity and women 
with obesity (Figure 3.3, p< 0.05). For example, men without obesity had significantly lower 
MVPA durations based on individualized cut-offs (16 ± 16.6 minutes/day) compared to MVPA 
durations based on standard cut-offs (89 ± 16.6 minutes/day) (p <0.05). Women with obesity had 
significantly lower MVPA durations based on individualized cut-offs (24.4 ± 13.8 minutes/day) 
compared to MVPA durations based on standard cut-offs (63.9 ± 13.8 minutes/day) (p <0.05). 
Discussion  
In our study, after accounting for individual differences in CRF, the individualized CPM 
cut-offs for denoting PA intensity were only higher than the standard CPM cut-offs for light PA 
intensity.  Men with obesity have lower CPM values than men without obesity. However, this 
difference in CPM cut-offs by obesity status did not translate into difference in PA volume as 
there was no difference in PA durations by obesity status using standard or individualized CPM 
cut-offs. Similarly, the proportion of individuals meeting the PA guidelines remained similar 
across all PA assessment methods.  
Our hypothesis was that individualized CPM values observed during PA should be lower 
for individuals with obesity when compared to individuals without obesity. Indeed, this was 
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precisely what we observed, suggesting that accelerometers will underestimate PA in men with 
obesity. However, there was no difference in CPM values in women by obesity status. In fact, 
women with obesity had higher CPM values when compared to women without obesity.  A 
previous study showed similar trends where the CPM values derived using standard CPM cut-
offs for moderate PA intensity (60% peak) were higher in women with obesity (6241 CPM) than 
women without obesity (5659 CPM) (77).   Sex differences  have been previously reported when 
participants were asked to wear uniaxial or triaxial accelerometer during PA (137,138). The 
differences that contribute to sex differences in accelerations produced at the hip are typically 
linked to biomechanical features, gait characteristics and anthropometric measures (139), and 
could relate to both the amount and distribution of skeletal muscle and body fat (140). Women 
tend to have greater adiposity in the hip and lower body region and higher levels of subcutaneous 
fat (141,142) . A greater adiposity in the hip among women with obesity could lead to added 
distance from the center of mass (COM) (143). The increased distance from the COM may 
contribute to increase in accelerations, resulting in inflated accelerometer CPM values in women 
with obesity. Thus, given the differences in adiposity among women, accelerometers positioned 
at hip may not work well in women.  
In accordance with previous literature, self-reported durations of PA were greater than 
accelerometers PA durations for all individuals and tended to be higher for individuals with 
obesity. It is often suggested that individuals with obesity tend to over-report PA while engaging 
in less over all PA compared to individuals without obesity (78,79,144). However, we do not see 
any difference in objectively measured PA durations by obesity status and it suggest that the 
difference from self-report could reflect the bias in the way accelerometers measure PA intensity 
and duration for individuals with obesity. The present findings are aligned with the previous 
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research conducted by Raiber et al (42), where the magnitude of the discrepencies between self-
report and accelerometer PA intensity and duration were reduced for individuals with obesity if 
they accounted for differences in estimated CRF from a sub-maximal test.  
 In the current study, for a given moderate or vigorous PA intensity, the individualized 
CPM cut-offs were not significantly different than the standard CPM cut-offs. However, the 
individualized CPM values ranged from 365 to 4997 CPM for light, 1675 to 10988 CPM for 
moderate and 4208 to 16804 CPM for vigorous PA intensities across sex and obesity status.  
Studies that examine various populations with different fitness levels based on body mass, age 
and sex report ranges of accelerometer CPM values for moderate intensity PA between 669 and 
7520 CPM (12,145).  Nevertheless, this extremely large range suggests that there may not be a 
single appropriate cut-off value to define PA intensity in a heterogeneous population. This large 
variability may contribute to the measurement error of accelerometers within a population and 
undermines the use of accelerometer in accurately measuring PA volume. This is in agreement 
with the idea that using absolute intensity PA standard CPM cut-offs are not appropriate for use 
in a population with ranging body mass (12).  
Durations of PA achieved will depend on the CPM cut-offs used (146,147). Lower CPM 
cut-offs will result in longer durations of measured PA. Conversely, using higher CPM cut-offs 
values will mean that more PA would not qualify as PA for a given intensity, resulting in shorter 
durations of PA. Even after accounting for CRF of individuals with obesity, durations of MVPA 
in both sexes ranged from 171 to 202 minutes/week. These values are likely relevant given that 
adults should engage in 150 minutes/week for positive health effects and 150 - 250 minutes/week 
for prevention of weight gain (54). Previous research has stated that individuals with obesity 
typically do not perform enough PA for health benefits and 60 to 77% of Canadians with 
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overweight or obesity do not meet the PA guidelines even when the PA is measured objectively 
(148).  Our study showed that there are no differences between individuals meeting the PA 
guidelines by obesity status. Based on the individual CRF, 52% of individuals with obesity and 
48% of individuals without obesity performed a minimum of 150 minutes of MVPA/week. 
Nonetheless, the current objective measures may not be able to adequately measure the PA 
volume and warrants further investigation.  
Some strengths and limitations are worth mentioning. To our best knowledge, this is one 
of the first studies to compare the accelerometer measured CPM values based on individual’s 
measured CRF to the commonly used Freedson’s CPM values and examined discrepancies by 
obesity status. The individualized CPM values were derived by using VO2 maximal exercise 
testing to avoid errors related to predicted maximum heart rate (220-age of participant [± 10 
beats/min]) and mechanical efficiency (e.g. VO2 at a given work rate). The exclusion of 
individuals who did not complete the VO2 maximal exercise test due to factors such as mobility 
issues or heavier weight could result in a sample that is healthier than the general population.  
In conclusion, after accounting for CRF, the individualized CPM cut-offs were not 
different than the standard cut-offs for moderate and vigorous PA intensities. Despite using the 
individualized CPM cut-offs, there were no differences in PA duration between individuals with 
or without obesity. Thus, future research is needed to better understand how to best translate 
CPM values into PA intensity plus duration and improve the use of accelerometers for assessing 
the impact of volume of PA participation in a population.  
 
 
 
 
  
 
 
62 
 
Table 3.1. Participant Characteristics by obesity status and sex 
 No Obesity Obesity  
Sample Size (n) Men (n=14) Women (n=7) Men (n=8) Women (n=12) 
Age (Years) 26.6 ± 9.5 29.6 ± 12.5 32.0 ± 13.1 29.1 ± 9.6 
BMI (kg/m2) 25.4 ± 2.3 21.3 ± 1.4 33.7 ± 4.1 33.2 ± 5.1 
Leg Length (cm) 104.9 ± 6.5 99.6 ± 5.2 103.2 ± 5.6 99.6 ± 5.0 
Waist Circumference 
(cm) 
88.3 ± 7.5 75.1 ± 9.2 112.9 ± 10.9 104.4 ± 12.4 
VO2peak 
 (mL.kg-1.min-1) 
53.9 ± 9.4 44.1 ± 7.2† 40.4 ± 14.3* 31.7 ± 7.3*† 
Values are presented as mean ± SD.  BMI= body mass index, VO2peak = Maximal Oxygen 
Uptake 
*= significantly different from same sex in no-obesity group (p <0.05) 
† = significantly different from same group but different sex (p <0.05) 
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Figure 3.1 
 
Figure 3.1. Accelerometer based individualized CPM values corresponding to 60% and 75% 
HRmax by sex and obesity status.  The models were adjusted for age (years) and leg length (cm).  
* = Statistically different from no-obesity group within same sex.  
HR= Heart Rate, CPM = Counts Per Minute 
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Figure 3.2 
 
Figure 3.2. Accelerometer based individualized CPM cut-offs of all participants and obesity 
status. The black dots are the individualized CPM cut-offs for each participant and the numbers 
above the black dots are the average CPM values of the group. Shaded areas depict PA 
intensities range based on standard cut-offs.   PA= Physical Activity, HR= Heart Rate, CPM = 
Counts Per Minute, OB = obesity.  
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Figure 3.3 
 
 
Figure 3. 3. Mean durations of moderate, vigorous and MVPA physical activity by obesity status 
and sex. PA = Physical Activity, MVPA = Moderate –to-vigorous Physical Activity  
* = Statistically different from standard cut-offs between the same obesity group 
† = Statistically different from individualized cut-offs between the same obesity group 
‡ = Statistically different from no-obesity group within the same PA assessment method 
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6.0 General Discussion  
The obesity rates using BMI increased at an alarming rate in the U.S. over the past three decades 
(2). The causes of obesity are multi-factorial and some of the factors are genetics, environmental, 
use of pharmaceutical drugs, physical inactivity and excess caloric intake (149).  Obesity is often 
linked to lost productivity and foregone economic growth as a result of lost work days, lower 
productivity at work, mortality and permanent disability (150). Even in research and clinical 
settings, individuals with obesity are often linked to increase in measurement errors in outcome 
measures (79,151,152). Thus, obesity is thought to constitute a threat to public health in terms of 
prevalence, incidence and economic burden.  
As the obesity rates have increased, obesity stigma has also increased by 66% in the U.S. 
over the past decade  (153). Unfortunately, weight discrimination and bias against individuals 
with obesity has appeared to be socially acceptable and is reinforced by the media (154,155).  
Health care providers are not that different when it comes to weight discrimination and bias as 
compared to the general public.  Research has shown that patients with obesity who perceive bias 
from their providers may cancel or delay appointments, as well as avoid preventative health care 
and screenings. Appointment delays and avoidance could further add to weight gain and obesity 
(156). Thus, the combined effect of obesity and its stigma has propelled us to explore obesity-
associated health outcomes, and measurement tools used in research to clearly define obesity and 
its consequences.  
The goal of obesity treatment (with or without weight loss) is to reduce obesity-
associated health risk factors. Our study showed that certain obesity-associated health risks have 
decreased over time. Given the stigma with weight status in health care settings and decreased 
prevalence of certain chronic conditions, it would be more beneficial and welcoming for 
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individuals with obesity if health care providers start drifting their conversations from weight 
status. Obesity is a multidimensional problem that requires a multidimensional response (53). 
Thus, health care providers should address this disease in a respectful and compassionate manner 
(157). Knowing that independent of obesity or weight status, certain health risks could be 
improved, the conversations between the health care providers and the patients should be more 
focused on the health outcomes. Our study reflects on the notion that there may be other factors 
that are attributing to the association of obesity with health risks over time. Thus, treatments 
could be more individualized, and the other factors may need to be more explored when 
providing health care to individuals with obesity.  
The use of BIA devices in estimating body composition and hydrations levels can be 
helpful for prognosis of certain diseases such as chronic obstructive pulmonary disease (COPD), 
and sarcopenic obesity  (158,159). Further, BIA could also be more sensitive in detecting 
pulmonary edema, fluid accumulation after cardiac surgery, and body fluids in hemodialysis 
patients  (160–162). However, it is yet questionable whether assessing %FM of healthy 
individuals is beneficial in a clinical setting. Further, BIA may not be able to provide accurate 
measures for individuals with high levels of obesity to physicians for disease prognosis (163).  
Nonetheless, BIA is a common method used for estimating body composition among individuals 
that are healthy and with diseases in research & clinical trials. Our study showed that BIA 
assumptions may not hinder the acute body composition measures beyond its day to day 
variability, which is crucial in clinical and research settings. 
It is important for individuals with obesity to engage in PA for health benefits. A single 
aerobic session can lead to reductions in blood glucose levels, triglyceride levels, blood pressure 
and improvements in insulin sensitivity and HDL levels (52,53). However, the current PA 
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measures such as accelerometers are not reflective of the accurate PA performed by individuals 
with obesity even when accounted for their CRF levels. Thus, better measures are required to 
property assess PA because it allows researchers to investigate the dose–response relationship 
between PA and health outcomes, and help shapes public health initiatives and interventions 
(51).  
In conclusion, despite increasing obesity using the BMI metric, the prevalence of obesity-
associated chronic conditions has decreased over the years. There may be other co-occurring 
temporal changes that have altered how obesity relates to chronic conditions. Thus, targeted 
efforts are needed to better define obesity and its associated health consequences. Future studies 
are also needed to explore factors other than obesity and their associations with chronic 
conditions. Further, there are certain biases to individuals with obesity using BMI when it comes 
to measurements of body composition and PA. Even when accounted for the CRF levels, current 
measures are not able to adequately capture the PA intensity and duration in individuals with 
obesity. Thus, better measures are needed for individuals with obesity to accurately depict PA 
intensity and duration.  
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Appendix B: Questionnaires used for Study 2 & 3  
 
1. Study Participant Data Collection Form – Study 2  
 
Subject ID:   __________________________________________    Date:______________        
 
Age: ____________________  Sex: ________________________________  
Height: __________________  Weight: _____________________________  
 
Visit 1: 
  Time since last Exercise bout: _________ hr 
  Time since last meal ________ hr 
  Water drank 3 L of water yesterday?   Y   N 
  Time since last drink: ____________hr 
  Time since Bladder last voided: ________ hr  
 
Condition BIA TANITA 
BC 
BIA TANITA 
TBF 
BIA OMRON Urine Specific 
Gravity 
Water (1)     
Control (3)     
Non-voided 
bladder (2) 
    
Exercise (4)     
 
 
Exercise Heart Rate: ___________ bpm 
Length exercised: ______________ min 
Speed, incline 
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Visit 2: 
  Not Exercised 
  Time fasted __________ 
  Water drank (12 hrs)________  
  Not Drink water hrs _________ 
  Bladder not voided min. 2 hrs___________  
 
 
Condition BIA TANITA 
BC 
BIA TANITA 
TBF 
BIA OMRON Urine Specific 
Gravity 
Dehydrated     
After meal     
 
 
 
 
Amount of fluids drank:____________________________ 
 
Amount of Pizza Eaten:____________________________ 
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2. The Importance of BIA Measure Assumptions Questionnaire – Study 2 
 
 
Participant ID:____________      Date: __________ 
Name:________________________    Phone Number:______________________ 
Email:________________________ 
 
Please answer the following questions: 
Gender:     Female    Male 
 
Age: ______   Date of Birth: ___________ (mm/dd/yyyy) 
 
Years and level of Education: _________________________ 
 
Ethnicity:  
    Aboriginal    African 
    Asian  
    Caribbean    European  
    Latin, Central, & South American    Middle Eastern 
    Pacific Islander 
    Other (please specify):______________________________ 
 
How much water do you consume per day on average?________  Cups/Litres 
How much fluids do you consume per day on average?________  Cups/ Litres 
When was the last time you drank fluids? ______(time) ______(date) ______(amt) 
When was the last time you ate? ______(time) ______(date) 
What was the last thing you ate? ______ 
 
Please list current medications you are taking: 
__________________________________________________________________
__________________________________________________________________ 
Would you be willing to take part in other studies? 
   Yes 
   No 
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3. Anthropometric data questionnaire  -Study 2  
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4. Study Participant Data Collection Form (Visit 1) – Study 3  
Subject ID: _______________ 
BMI __________________                      
Visit date:   __________________                  Age:                         years           Sex: _________                
Height:                   m                        ft.inch              Weight:                      kg                              lbs                                 
% Body Fat               __________________(Omron)                __________________(Tanita)  
Limb Length (cm) 
• Knee Height (above patella to floor): ___________________  
• Leg length (ASIS to floor): __________________  
• Thigh length (inguinal ligament to top of patella): __________________  
• Trunk length (top of trap to chair ): __________________  
Circumferences (cm)   1   2 
• Waist (iliac crest):        ____________ _____________ 
• Hip (Max Gluteal):    ____________ _____________ 
• Thigh (Right Proximal):  ____________ _____________ 
• Bicep (Right Midpoint):   ____________ _____________ 
Body Diameters (cm)  
• Abdominal depth: __________________ 
• Hip width :__________________  
Stride length (step count per 5 meters): ____________steps/5m 
Bruce Treadmill Test (Cardio coach monitor–modified Bruce protocol) 
• VO2 max:                             ml/kg/min          Peak HR:                          beats/min 
Accelerometer (7-day wear) 
• Start date:                                         2017                  End date:                                          
2017 
Notes:  ___________________________________________________________________  __  __  __  
__  __  
___________________________________________________________________  __  __  __  __  __              
Bruce Treadmill Test (Cardio coach monitor–modified Bruce protocol) 
Warm up-  for different speed, get the intial speed at a RPE score of 4-6.  
• Real time: At start of VO2 test___________     
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• Timer time at start:  __________   
• Total test time (when the test is complete):  ________ min:sec  
Stage 1 (0-3 mins): 
• speed: _______________  mph          gradient:____________ 
Stage 2 (3-6 mins): 
• speed: _______________  mph          gradient:____________ 
Stage 3 (6-9 mins): 
• speed: _______________  mph          gradient:____________ 
Stage 4 (9-12 mins): 
• speed: _______________  mph          gradient:____________ 
Stage 5 (12-15 mins): 
• speed: _______________  mph          gradient:____________ 
Stage 6 (15-18mins): 
• speed: _______________  mph          gradient:____________ 
VO2 max:                             ml/kg/min          Peak HR:                          beats/min 
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Study Participant Data Collection Form (Visit 2) 
Visit date:                                         2017           Subject ID: _______________ 
Treadmill Walk/jog  
• ___________(2mph, 1% grade, 3 minutes):_______________ 
• ___________(3mph  1% grade, 3 minutes) :_______________ 
HR Targets (beats/min) 
• MVPA intensity (≥50% of VO2max): _______________ 
• Light intensity (30-35% of VO2max): _______________ 
Field Testing 
• Total test time: _______________ 
MVPA             LIGHT PA 
Bout Stopwatch Time  Real Time  Bout Stopwatch Time Real Time 
1   1   
2   3   
3   3   
4   4   
5   5   
6   6   
7   7   
8   8   
9   9   
10   10   
 
  
 
 
104 
Appendix C: Additional Related Publications 
 
1. Yu WW, Randhawa AK, Blair SN, Sui X, Kuk JL (2019).  Age- and sex- specific all-
cause mortality risk greatest in metabolic syndrome combinations with elevated blood 
pressure. (accepted, 8299f2989ac8b6 PLoS ONE). 
 
2. Raiber L, Randhawa AK, Christensen R, Jamnik VK, Kuk JL (2018). Do moderate to 
vigorous intensity accelerometer count thresholds correspond to relative moderate to 
vigorous intensity physical activity? (apnm-2017-0643, Applied Physiology, Nutrition 
and Metabolism) 
 
3. Parikh JS, Randhawa AK, Wharton S, Edgell H, Kuk JL (2018).  The association 
between antihypertensive use and blood pressure is influenced by obesity. (Journal of 
Obesity, https://doi.org/10.1155/2018/4573258 
 
4. Randhawa AK, Parikh JS, Kuk JL (2017).Trends in medication use by body mass index 
and age between 1988 and 2012 in the United States. PLoS ONE Sep 20;12(9):e0184089. 
doi: 10.1371/journal.pone.0184089. 
 
5. Brown RE, Randhawa AK, Canning KL, Fung M, Jiandani D, Kuk JL (2017).  Waist 
Circumference at five common measurement sites in normal weight and overweight 
adults: which site is most optimal? (COB-17-OA-0037.R, Clinical Obesity) 
 
6. Jiandani D, Randhawa AK, Brown RE, Hamilton R, Matthew AG, Kuk JL, Alibhai 
SMH, Tufts E and Santa Mina D (2015). The effect of cycling on prostate-specific 
antigen (PSA) levels: a systematic review and meta-analysis. Prostate Cancer and 
Prostatic Diseases 18, 208-212 doi:10.1038/pcan.2015.16 
 
7. Sohni S, Randhawa AK, Wharton S, Kuk JL.  Association maternal factors and weight 
loss in adult offspring (under preparation, 2019) 
 
8. Swaze S, Sohni S, Randhawa AK, Zaki K, Kuk JL. Taste Difference of organic vs non-
organic food (under preparation, 2019) 
 
